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Abstract 
In "Shen Nong's Herbal" of the East Han dynasty in China, the beneficial 
effects of various fungi were already illustrated. In the last three decades, many 
studies have focused on the antitumor and immunomodulatory effects of mushroom 
polysaccharides and exploited their potential as clinical anticancer drug or adjuvant. 
In this project, the famous edible long-veiled lady mushroom Dictyophora indusiata 
was selected for both in vivo and in vitro antitumor studies of its polysaccharides, 
which have received only little attention in research. 
Three DI3 polysaccharides fractions were extracted from Dictyophora indusiata, 
and designated as DI3a，DI3b and DBc, respectively, in present study. They were 
isolated by water extraction and ethanol precipitation, followed by anion-exchange 
fractionation. DBc fraction is relatively homogenous protein-containing 
polysaccharide with molecular weight of 3.3 kDa, while the fractions DI3b and DBc 
contained more than one group of polysaccharides. Using in vivo antitumor study, 
DBc exhibited the most prominent antitumor activity in Sarcoma 180 tumor-bearing 
BALB/c mice. Administration of 50 mg/kg of DBc fraction for 10 consecutive days 
(i.p.) could inhibit the growth of Sarcoma 180 solid tumor by 76%. In the study of 
cytokine production in blood serum, DBc fraction not only induced the production 
ii 
of TNF-a, but also primed the LPS-triggered TNF-a production at a higher level. 
However, no up-regulation of IL-2 was observed. DI3c did not inhibit the growth of 
S-180 cell in vitro, and hence, the anti-tumor activity of DBc is thought to be due to 
the immunomodulatory effect via TNF-a production at least partially. On the other 
hand, in vitro studies showed that, DI3b fraction could inhibit the proliferation of 
HL-60 and HepG2 cells significantly in a dose-dependent manner. At the dose of 200 
|ig/ml, DI3b could give 50% inhibition rate on proliferation of HL-60 cells after 72 h 
incubation. The dose-dependent antiproliferative effect of DI3b fraction on HL-60 










本研究於竹藉中提取了多糖D I 2和D I 3，並於D I 3多糖中再萃 
提出三個多糖部份，分別命名為D I 3 a �D I 3 b及D I 3 c °在三個D I 3 
多糖部份當中，DI3C是較純化多糖蛋白部份，分子量約為3.3 kDa° 









反，D I 3 c對白介素 - 2 ( IL-2)的製造並無任何作用。此項實驗顯示 
D I 3 C的抗腫瘤作用與T N F - a的製造有直接的關係。 
於體外抗腫瘤實驗中，多糖DI3b部份對白血細胞HL-60及肝癌 
細胞HepG2，均具有抑制增殖作用，並表現出劑量依賴性抑制。經 
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In the last three decades, it had been recognized that mushroom polysaccharides 
show a wide diversity of pharmacological activities, including antitumor, 
immunomodulatory, antiviral, hypoglycermic and free radical scavenging activities. 
Most of the studies are mainly focused on the antitumor and immunomodulatory 
effects of mushroom polysaccharides from the class of Basidomycetes (Wasser & 
Weis, 1999). Although, the chemotherapy has been established and widely used in 
clinical anticancer treatment, there is still an increase in significance in exploring 
mushroom polysaccharides with antitumor effects due to the dissatisfaction and 
occurrence of side effect by the current chemotherapy. 
Among the mushroom polysaccharides that have been investigated in the last 
thirty years, they are mainly antitumor p-glucan, heteroglycan and polysaccharide 
protein complexes. Lentinan, which has been used in clinical anticancer treatment, is 
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Introduction 
a purified (l->6)-(3-D-glucan isolated from Lentinus edodes. The research done by 
Chihara et al (1970) had demonstrated the prominent antitumor effect of lentinan 
against Sarcoma 180 cells in Swiss albino mice and SWM/MS mice. After treated 
with a dose of Img/kg of lentinan for 10 consecutive days, complete regression of 
tumor was observed in tumor-bearing SWM/Ms mice (Chihara et al., 1970). Besides, 
as suggested by Maeda & Chihara (1971), the antitumor effect of lentinan was 
shown to be contributed by the immune system, since the antitumor activity of 
lentinan was lost in neonatally thymectomized mice (Maede & Chihara, 1971). 
Although the mechanism that mushroom polysaccharides produce their 
antitumor action is very complicated and shows differences between mushroom of 
different species, it seems that most of the immunomodulatory activities produced 
are correlated to the modulation of cytokine production in the host, for example the 
antitumor effect of lentinan is to up-regulate the IL-la, IL-ip, TNF-a and IFN-y in 
mice so as to enhance the immune system of the host to act against the tumor cells 
(Liu et a\., 1999). In order to study the cytokine expression induced by mushroom 
polysaccharides, different kinds of studies were applied, including Northern blot and 
reverse transcriptase polymerase chain reaction (RT-PCR). The immunomodulatory 
effects in cytokine production by the polysacchariopeptide (PSP) from Coriolus 
versicolor and polysaccharides-protein complex (PSPC) from Tricholoma lobayense 
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were analyzed by northern blot and RT-PCR, respectively, in different studies (Liu et 
al., 1993; Liu et al., 1999). Besides, by using indicator cells or enzyme-linked 
immunosorbent assay (ELISA), the cytokines present in biological fluid can also be 
measured. 
Although most of the mushroom polysaccharides posses antitumor activity 
through immunomodulation, it may not be neglected the in vitro antiproliferative 
effect on cancer cells. In a recent in vitro study, a Ganoderma lucidum 
polysaccharide was found to exhibit antiproliferative effect on K-562 leukemic cells 
in a dose and time-dependent manner (Zhong et al., 1999). Besides, restoration of 
cell cycle regulation was also observed in some other anticancer substances. One of 
the examples is ceramide, which produces antiproliferative effect on leukemic cells 
by acting as a key regulator in preventing progression through G1 to S phase in the 
cell cycle (Connor et al., 2001). In order to investigate the antitumor effect produced 
by mushroom polysaccharides in detail, it is worth for us to perform the in vitro 
antitumor study in parallel to that of in animal model. 
In the present study, edible long-veiled lady mushroom Dictyophora indusiata, 
which belongs to the class of Basidomycetes, was selected for investigation. It is a 
beautiful, phallic shaped mushroom and distributed mainly in China and Japan. In 
the previous studies, six different mushroom polysaccharides have been isolated 
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from Dictyophora indusiata (Ham et al； 1982a, 1982b, 1983，1986, 1988 & 1991; 
Ukai et al., 1980, 1982 & 1983) and their antitumor effect was also studied by Ukai 
et al. (1983). However, the in vitro anticancer effects as well as the actions of the 
mushroom polysaccharides in producing antitumor activities have not been 
investigated in those studies. Polysaccharides from fruit bodies Dictyophora 
indusiata were isolated and fractionated in this study. Both in vivo and in vitro 
studies were performed to study the effectiveness of the polysaccharides fractions in 
inhibiting the growth of tumor. In order to study the mechanistic action of antitumor 
effect in the mouse model, enzyme-linked immunosorbent assay was also used in 





2.1 Mushroom Polysaccharides from Basidiomycetes 
Mushroom has been exploited as food for thousands of years throughout the 
world especially in China and Japan. Both fresh and dried mushrooms are used as 
materials in Chinese, Japanese and Western cuisine, due to their excellent flavor and 
texture. Besides, it has been shown that most mushrooms have high nutritional value 
and may serve as a source of dietary protein, essential amino acids, fiber, vitamins 
and minerals. Furthermore, mushrooms have a high proportion of unsaturated fatty 
acid and a low content in calories, sodium, fat and cholesterol. Apart from the 
nutritional value, mushroom also has a long history in medicinal purpose. In “Shen 
Nong's Herbal" of the East Han dynasty in China (100-200AD), the beneficial 
effects of various fungi such as Ganoderma lucidum, Poria cocos and Tremella 
fuciformis were illustrated. 
-5-
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In the last three decades, the study of pharmacological activities of mushrooms 
in the class of Basidiomycetes has become matter of interest. Since, the 
polysaccharides extracted from Basidiomycetes have been served as bioactive 
components that express promising antitumor, immunomodulatory (Ooi and Liu, 
2000), antiviral (Tsukagoshi et al., 1984; Eo et al., 1999)，hypoglycermic (Hikino et 
al” 1985), free radical scavenging (Liu et al., 1996a) and other medicinal activities 
(Cheung, 1996; Park et al., 1997; Kiho et al； 2000) 
2.1.1 Antitumor and Immunomodulatory Activity 
Due to the dissatisfaction and occurrence of side effect with current cancer 
chemotherapy, polysaccharides extracted from mushrooms have become great 
interest as antitumor substances. As the fruiting body and liquid-cultured mycelium 
of higher Basidiomycetes have been found to contain polysaccharides that exhibit 
antitumor and immunomodulatory activities, therefore the discovery for new 
antitumor substances from mushrooms has become more and more popular. 
In the last few decades, many of the mushroom polysaccharides extracted from 
higher Basidiomycetes have been subjected to various antitumor studies, for 
examples, polysaccharides derived from mushrooms Lentinus edodes, Hericium 
erinaceum, and Ganoderma lucidum. 
-6-
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Lentinan, which is derived from Lentinus edodes, is a purified 
(1—3)_p_D-glucan with (1 ->6)-P-D-glucopyranoside branches. It is successfiilly 
used as immunotherapeutical drug in clinical treatments for cancer patients. Lentinan 
administered at a dose of 1 and 5 mg/kg for 10 consecutive days after implantation 
of Sarcoma 180 cells in Swiss albino mice could significantly inhibited the growth 
of Sarcoma 180 solid tumor by 95.1 and 97.6%, respectively (Chihara et aL, 1970). 
Complete regression of Sarcoma 180 was also observed in 6 out of 10 mice treated 
with a dose of 1 mg/kg, and 7 out of 10 mice treated at a dose of 5 mg/kg. Other than 
in Swiss albino mice, lentinan could inhibit the growth of Sarcoma 180 by almost 
100% at dose of 1 mg/kg in the mice model of SWM/Ms mice (Chihara et aL, 1970). 
h e is a hot water extract isolated from Hericium erinaceum. Oral administered 
of HE could inhibit the Sarcoma 180 solid tumor in ICR mice at the dose of 500 
mg/kg and 250 mg/kg, respectively, by 51.8% and 47.2%. However intraperitoneal 
administration of 100 mg/kg and 50 mg/kg of HE exhibited inhibition of Sarcoma 
‘ 180 growth by 63.0% and 55.8%, respectively (Itoh et aL, 1999). 
Moreover, mushroom polysaccharides GL-B, which was isolated from 
Ganoderma lucidum also showed significant antitumor effect in a dose dependent 
maimer in vivo study. GL-B at dose of 50, 100 and 200 mg/kg, respectively, showed 
inhibitory activity on Sarcoma 180 cells in BALB/c mice by 27.70%, 55.83 & and 
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66.70% (Zhang & Lin，1999). 
Although many studies reveal mushroom polysaccharides could exhibit 
antitumor activity in animal model, it seems that the antitumor effect of mushroom 
polysaccharides is not due to the direct attack on tumor cells, but may produce their 
antitumor activities by activating different host immune responses. 
According to the studies by Zhang & Lin (1999), GL-B could not inhibit the 
proliferation and induce apoptosis in HL-60 cells in vitro study. However in 
apoptosis analysis by using flow cytometry, apoptotic cells were observed in HL-60 
cells, which have been incubated with the conditioned medium from GL-B activated 
macrophage (GL-B-M-CM) and the conditioned medium from GL-B activated T 
lymphocyte (GL-B-T-CM). This result illustrated that macrophage and T 
lymphocyte both contributed in inducing apoptosis by GL-B on HL-60 cells. Besides, 
mushroom polysaccharides MGLPl and MGLP2, which were extracted from the 
mycelium of Ganoderma lucidum, also showed similar effect as that of GL-B (Hu & 
Lin, 1999). MGLPl and MGLP2 both did not exhibit inhibitory effect on 
proliferation on HL-60 cells in vitro, while when MGLPl and MGLP2 treated with 
the splenocyte in culture medium, it could induce HL-60 apoptosis. The result 
obtained from these two studies suggested that the antitumor effects of GL-B, 
MGLPl and MGLP2 might be due to the activation of cytokine production by 
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macrophage, T-lymphocyte and splenocyte. As suggested by the author (Zhang & 
Lin, 1999), GL-B treated macrophage and T-lymphocyte might activate the 
production of TNF-a and IFN-y. Whereas MGLPl and MGLP2 treated splenocyte 
activated the production of IL-2, which could enhance the synthesis and secretion of 
INF-y by T-lymphocyte. The INF-y secreted may further activate the change of 
pre-cytotoxic T lymphocyte into mature cytotoxic T lymphocyte (Hu & Lin, 1999). 
TNF-a and IFN-y have the ability in induction of apoptosis, whereas IFN-y and 
cytotoxic T lymphocyte can inhibit the growth of tumor cells. 
On the other hand, in the antitumor study of lentinan by using neonatal 
thymectomized mice, the inhibition on the Sarcoma 180 solid tumor was 6.4%, 
while the tumor inhibition rate in normal mice was 99.6%. This result also illustrated 
thymus has played an important role in the antitumor action of lentinan and it is 
responsible for the cell-mediated response in immune system that stimulated by 
lentinan as well (Maeda & Chihara, 1971). 
2.1.2 Antiviral Activity 
GLhw, which is a polysaccharides fraction isolated from the carpophores of 
Ganoderma lucidum by hot water extraction followed by ethanol precipitation, 
showed antiviral activity against herpes simplex virus type 1 (HSV-1) and herpes 
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simplex virus type 2 (HSV-2). GLhw showed cytopathic effect (CPE) inhibitory 
activity on confluent Vero cells with an E C 5 0 of 1510 and 1790 jiig/ml against HSV-1 
and HSV-2, respectively, whereas the C C 5 0 of GLhw on the host cells is 7860 |Lig/mL 
Besides, GLhw inhibited plaque formations of HSV-2 on Vero and Hep-2 cells in a 
dose dependent manner with an E C 5 0 of 590 and 580 |ig/ml, whereas the C C 5 0 of it 
are 880 and 1230 M^ g/ml respectively (Eo et al., 1999). 
Similar to GLhw, a polysaccharide protein complex isolated from the cultivated 
mycelium of Coriolus versicolor (PSK) also acts as an antiviral substance when 
administered intraperitoneally or intravenously into ICR mice. Pre-treatment or 
post-treatment of PSK is able to enhance the resistance to the infections of 
ectromelia virus and cytomegalovirus and prolong the survival time in mice model 
(Tsukagoshi et al., 1984). 
Pleuran, an alkali insoluble (3-D-glucan isolated from Pleurotus ostreatus, has 
been reported to express antiviral activities against Haemophilus influenze as well. 
Intraperitional administration of pleuran promoted survival of mice susceptible to 
pulmonary Haemophilus influenze infection in a dose dependent manner 
(Karacsonyi & Kuniak, 1994). 
Besides, lentinan derived form mushroom Lentinus edodes, when used in 
combination with azidothymidine (AZT), inhibit human immunodeficiency virus 
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(HIV) more effective than that of AZT alone (Tochikura et al； 1987). 
2.1.3 Hypoglycermic Activity 
Hypoglycemic activity is also exhibited by mushroom polysaccharides 
Ganoderans A and B. These two polysaccharides are both obtained from hot water 
extraction followed by ethanol precipitation from the fruiting bodies of Ganoderma 
lucidum. Intraperitoneal injection of Ganoderan A and B in normal and 
alloxan-induced hyperglycemic mice elicited strong hypoglycemic and plasma sugar 
lever lowering activities (Hikino et al., 1985) 
2.1.4 Free Radical Scavenging Activity 
Free radical scavenging activity is also observed from mushroom 
polysaccharides. The polysaccharide extracts from fruiting bodies of Ganoderma 
lucidum and Grifola umbellata inhibited the superoxide radical generation by 82.7% 
and 74.8% respectively in phenazin methosulphhate-NADH-nitroblue tetrazolium 
system at concentration of 80 |Lig/ml (Liu et al., 1996a). Besides, the changes in 
proportion of protein in the polysaccharides extracts also affect the scavenging 
activity, as the polysaccharides to protein ratio decreased, the superoxide radical 
scavenging activity would be increased. PSK and polysaccharides extracts of G. 
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lucidum also inhibited the hydroxyl radical generation by 54.14% and 45.75% 
respectively in ascorbic acid-Cu^' -cytochrome C system at concentration of 400 
[ig/ml (Liu et al” 1996a). 
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2.2 Mushroom Dictyophora indusiata (竹蒸) 
Dictyophora indusiata is referred as a “long veiled lady mushroom", because its 
appearance looks like a lady wearing a long dress. It is a very beautiful, phallic 
shaped mushroom, which is widely distributed in China (known as Zhu Sun), Japan 
(known as Kinugasatake), Africa as well as South America. D. indusiata is an edible 
mushroom belongings to the class Basidiomycetes, order Phallales and family 
Phallaceae (徐I帛堂，1997). It has been reported to have antihypertensive, blood lipid 
lowering, cholesterol lowering (徐錦堂，1997;張樹庭及即曉處，1995) and 
antimicrobial activities (Tan & Hu, 1999). In addition, D. indusiata is also used as 
folk remedies for the treatment of dysentery (徐錦堂，1997). 
Since D. indusiata has been used as a nutritious food and medicinal drug in 
China, there are various studies in examining the nutritional value, structural 
characteristic and biological activities of this mushroom and its isolated 
polysaccharides 
2.2.1 Nutritional Value 
Dictyophora indusiata have been considered as a nutritious food and one of 
most delicious mushrooms. According to a study, twelve inorganic elements, vitamin 
E, fifteen amino acids (including valine, leucine, threonine, methionine, lysine and 
-13-
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pheuylalanine were determined in this mushroom (Ouyang et al., 1998). 
2.2.2 Structural Characteristic of Dictyophora indusiata Polysaccharides 
Six homogenous polysaccharides (T-2-HN, T-3-M, T-3-G, T-4-N, T-5-N, and 
T-3-Ad) and a conjugated polysaccharide fraction (T-2-A) have been obtained from 
the fruit bodies of mushroom D. indusiata in various studies. 
T-2-HN and T-3-M both were partially (9-acetylated (1 ^ 3)-a-D-mannan. 
T-2-HN and T-3-M were protein-free polysaccharides, since they were deproteinized 
in the isolation process by the Pronase treatment and Sevag method (Ukai et al., 
1980; Hara et al., 1986). According to the methylation analysis by Hakomori 
procedure, T-2-HN was a linear chain composed of a-l->3 linked 
D-mannopyranosyl residues (>97%) and traces of 1—6 linked D-mannopyranosyl 
residues (Ukai et al., 1980), whereas T-3-M composed of 
2,4,6-tri-O-methyl-D-mannopyranose with a negligible proportion of 
2,3,4,6-tetra-O-methyl-D-mamiose (Hara et al” 1988). On the other hand, the result 
obtained from periodate oxidation and Smith degradation showed that T-2-HN 
contains appoximately one acetyl group (11.4%) per two D-mannosyl residues in the 
3)-linked D-mannopyranosyl chains and 88% of the acetyl groups were 
located on 0-6 of the D-mannosyl residues (Hara et <2/., 1982). Besides, T-3-M 
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contained a- (l->3)-linked D-mannopyranosyl residues (Hara et al., 1988). In 
addition, the molecular weight of T-2-HN and T-3-M were estimated by gel 
chromatography on a Sepharose 2B column and Sepharose CL-2B respectively. The 
molecular weight ofT-2-HN (-6.2x10^) is higher than that of T-3-M (-1.9x10^). 
Apart from the partially 0-acetylated (1^3)-a-D-mannan, P-D-glucans (T-3-G, 
T-4-N and T-5-N) were also isolated from D. indusiata. T-3-G, T-4-N and T-5-N 
were isolated from a hot-water extract (Hara et al., 1986), 2% sodium carbonate 
extract (Hara et al., 1983)，and alkaline (IN sodium hydroxide) extract (Ukai et al., 
1982) of the fruit bodies of D. indusiata respectively. Since these three 
polysaccharides were p-D-glucans, they all possessed a main chain of 
3)-linked D-glucopyranosyl residues with branches consisting of a single 
|3-(l->6)-linked D-glucopyranosyl groups attached to the main chain. However, the 
molecular weight and location of the side chain were different in these three 
3-D-glucans. The molecular weight determined by gel filtration on Sepharose CL-2B 
using 0.25 M sodium hydroxide as eluant were 5.1 x 10 ,^ 5.5 x 10^  and 3.3 x 10^in 
T-3-G, T-4-N and T-5-N respectively. Besides, the side chains |3-(1—6)-linked 
D-glucopyranosyl groups of T-3-G and T-4-N were attached on average to every 
fifth sugar residue, whereas that of T-5-N were attached on average to every seventh 
sugar residue of the main chain (Ukai et al., 1982; Hara et al., 1983; Hara et al., 
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1986). Moreover, as reported by Hara et al (1986), T-3-G might be one of the 
cell-surface glycans of D. indusiata, and T-4-N and T-5-N might be the components 
that were present either in the cell wall or inside the cells ofD. indusiata (Hara et al., 
1986). 
Other than T-3-G, a conjugated polysaccharide fraction, fucomannogalactan 
(T-3-Ad) was also isolated from the hot-water extract of fruit bodies of D. indusiata. 
T-3-Ad is a heterogalactan, which was composed of L-fucose, D-mannose and 
D-galactose (Hara et al” 1991). 
2.2.3 Biological Activity 
Dictyophora indusiata polysaccharides have been reported to possess 
anti-inflammatory (Hara et al., 1982b), mitogenic, colony stimulating 
factor-inducing (Hara et al., 1991) and antitumor activities (Ukai et al., 1983). 
T-5-N was able to inhibit carrageenan-induced edema and scalded edematous 
hyperalgesia in Sprague Dawley (SD) rat's hindpaw at dose of 12 or 25 mg/kg (i.p. x 
2) and 25 mg/kg (i.p. x 2) respectively. The result showed the effects of T-5-N were 
stronger than 25-50 mg/kg (i.p. x 2) of phenylbutazone (Hara et al,, 1982b). 
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Table 2.1 Dictyophora indusiata polysaccharides. 
Polysaccharides Polysaccharides Type Molecular weight Reference 
(Dalton) 
T-2-HN O-acetylated (1^3)-a-D-mannan 6.2 x 10^ Hara et fll.，1982a 
Ukai et al” 1980 
T-3-M a-(1^3)-lmked-D-mannan 1.9 x 10^ Hara et al； 1988 
T-3-G (l->6)-branched (1^3)-p-D-Glucaii 5.1x 10^ Hara et al” 1986 
T-4-N (l->6)-branched (1^3)-p-D-Glucan 5.5 x 10^ Hara et al., 1983 
T-5-N (1—6)-branched (l->3)-p-D-Glucan 3.3 x 10^ Ukai et al” 1982 
T-3-Ad Fucomannogalactan 1.4 x 10^ Hara et 1991 
T-2-A Conjugated polysaccharide fraction --- Hara et al., 1991 
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Moreover, it was proved that the polysaccharide fractions extracted from the 
fruit bodies of D. indusiata were able to enhance the immune response. T-3-Ad, 
T-4-N and T-2-A could exhibit mitogenicity for murine lymphocytes and colony 
stimulating factor (CSF)-inducing activities in blood of mice. Among these three 
polysaccharides extracts, T-2-A was showed to have the most potent effect (Hara et 
aL, 1991). 
In additional to the mitogenic and CSF-inducing activities, D. indusiata is 
known to contain polysaccharide compounds having antitumor activity when 
intraperitoneally administered. T-2-HN, T-4-N and T-5-N were shown to exhibit 
anti-tumor activity against Sarcoma 180 ascites cells. In the experiment done by 
Ukai et al； (1983) intraperitoneal administration of T-2-HN at dose of 25 mg/kg/d 
xlO, T-4-N and T-5-N at dose of 10 mg/kg/d xlO gave inhibition rates of 77%, 25% 
and 77% of the control respectively (Ukai et al., 1983). 
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2.3 In vivo Antitumor Study 
The use of Sarcoma 180 cells has been well established for in vivo antitumor 
studies, though the animal model, site and route of tumor cells implantation and the 
period of treatment are different in many studies (Liu et al； 1995; Mizuno et al., 
1995; Itoh et al., 1999; Ohno et al., 2000). Although most of the studies are 
anti-solid S-180 tests, the anti-ascitic S-180 activity of the culture filtrates from 
Schizophyllan commune and Tricholoma sp. was also evaluated in additional to 
anti-solid S-180 activity (Komatsu et al., 1969; Liu et al., 1995). 
The researches always use mice as their animal model, since they are easy to 
handle and have a rapid breeding cycle. The commonly used mouse models are 
BALB/c and ICR mice. The best sites for tumor cells implantation are intramuscular 
(i.m.) in the leg or subcutaneous (s.c.) over the lower back of the mice, since the 
tumor size can be measured easily (Begg, 1987). Besides, the period of treatment 
and the whole experiment are different in many studies; it usually ranged form 10 
days to 18 days and 14 days to 35 days respectively. For example, HE, a hot-water 
extract of Hericium erinaceum was administered to ICR mice starting on the day 
before the implantation of tumor cells once daily for 18 days, and the tumor was 
excised 14 days after the implantation. On the other hand, the 1,3-p-glucan isolated 
from cultured fruit body of Sparassis crispa was administered for 10 consecutive 
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days from 24 hours after the tumor inoculation, and the tumor was excised 35 days 
after tumor inoculation. Besides, the anti-tumor effect has been evaluated by using 
different parameters, such as percentage of tumor inhibition, regression of tumor and 
mortality of the tumor bearing mice. 
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2.4 Induction of Cytokines Production in Immune System 
Cytokines are a diverse group of small soluble glycoprotein (<30kDa) (Wise & 
Carter, 2002), and its main function is to act as intercellular signals within immune 
system (Kelso, 1998). They encompass families of regulators, including interleukins 
(IL), tumor necrosis factors (TNP), interferons (IFN) and certain growth factors, and 
are produced by every nucleated cell in the body. Besides, Cytokine synthesis is a 
consequence of cellular activation, which is induced by a various kinds of exogenous 
and endogenous stimuli, depending on the nature and the differentiation or activation 
state of the secreting cell; for example, antigen or antigen-MHC can trigger the 
cytokines production by B or T cell (Kelso, 1998). 
Since most of the antitumor effects in vivo are due to immunomodulatory 
activity rather than direct cytotoxicity, the measurement of cytokines production is 
applied in order to study the regulation of cytokines in the host immune system. 
Cytokine expression, synthesis and secretion were investigated by various 
techniques in different researches, including: cytokine-specific mRNA expression 
analysis and the assay of secreted cytokines in supernatant or biological fluid. 
In the analysis of cytokine-specific mRNA expression, both Northern blotting 
as well as reverse transcriptase polymerase chain reaction (RT-PCR) were applied in 
different studies. Northern blot analysis was used by Liu et al. (1993) to study the 
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expression of TNF by adherent peritoneal macrophages collected from 
polysaccharopeptide (PSP) treated C57 mice (Liu et al., 1993). Besides, by using 
RT-PCR techniques, the cytokine mRNA can be isolated with the aid of specific 
primer. For example, the immunomodulating activity of mushroom polysaccharides 
was evaluated by using RT-PCR. The cytokine gene expression of 
polysaccharide-protein complex (PSPC) and lentinan was compared by RT-PCR 
using primer specific for IL-la, IL-ip, TNF-a, IFN-y and macrophage-colony 
stimulating factor (M-CSF) (Liu et al., 1999). According to the result, both of the 
mushroom polysaccharides were able to up-regulate IL-la, IL-ip, TNF-a, IFN-y and 
M-CSF in ICR mice. Moreover, the cytokine gene expression induced by a highly 
branched (l->3)-P-D-glucan (OL-2) administration in different mice model (ICR 
and AKR mice) were also compared by RT-PCR by Nemoto et al. (1994). Since 
AKR mice is a strain with a genetic C5 deficiency, the difference pattern of cytokine 
gene expression induced by OL-2 in ICR and AKR demonstrated the complement 
cascade was contributed in OL-2- induced cytokine gene expression (Nemoto et al., 
1994). 
Different cytokines may be present in biological fluid (including serum, plasma) 
or culture supernatant, therefore the assay of secreted cytokines is used by 
researchers as well. The determination of secreted cytokines, which is based on the 
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bioactivity and receptor-binding properties of the cytokines, were carried out by 
using indicator cells and enzyme linked immunosorbent assay (ELISA), respectively. 
As each different cytokine may have its specific biological activity, a suitable 
indicator has to be employed in order to identify a particular cytokine. The 
proliferative response of the indicator cells is usually assessed by [^H] thymidine 
uptake, MTT reduction assay or crystal violet staining. For example, in the study of 
mushroom lectins from Tricholoma mongolicum on immunomodulatory activity 
(Wang et al., 1996b), established cell line L929 mouse fibroblast has been used for 
measuring the biological activity of TNF. The proliferation response of L929 was 
defined as percent inhibition of L929 growth by crystal violet staining. And in the in 
vitro study of a purified (1^3)-P-D-glucan (GRN) in activation of cytokine 
production, which was isolated from the mushroom Grifola frondosa, the production 
of IL-1 in the culture supematants and the macrophage cell lysates was determined 
in terms of the thymocyte proliferation response by [^H] thymidine uptake by Adachi 
et al. (1994). The indicator cells thymocytes used in this experiment were freshly 
isolated from C3H/HeJ mice (Adachi et al” 1994), whereas L929 is an established 
cell line. 
Due to the availability of large amounts of recombinant cytokines and 
monoclonal anti-cytokine antibodies, sandwich type of ELISA has been applied in 
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the immunoassay of cytokines. In this immunoassay, the measurement of cytokine is 
based on the colorimetric determination of enzyme activity (for example, avidin-
alkaline phasphatase or avidin-horseradish peroxidase) coupled to the detecting 
antibody. In a recent study by Tokunaka et al. (2000), ELISA was used to study the 
immimopharmacological activity of a Candida water-soluble (l->3)-p-D-glucan 
(CSBG). In this study, rat monoclonal anti-mouse TNF-a and rabbit polyclonal 
anti-mouse TNF-a antibodies were used for capture and detection of TNF-a in 
mouse serum, respectively. CSBG is able to prime the production of TNF-a after 
lipopolysaccharides (LPS) administration (Tokunaka et al., 2000) as most P-glucan 
(GRN, SPG, SSG and ZYM) in the study by Ohno et al. (1995). 
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2.5 In vitro Antitumor Study 
In antitumor study in vitro, different means for quantifying cell population can 
be utilized to assess the proliferation and cytotoxicity of the drugs on cancer and 
normal cell lines respectively, for example, direct cell count, colorimetric 
measurement and [^H]-thymidine/ BrdU incorportion. 
Cell density and viability can be determined by the actual enumeration of cells 
by direct microscopy or automated cell counting. Trypan blue exclusion method is 
the most primitive, simple and widely used method in direct cell count. This was 
performed by counting cells of preparations with a microscopic counting chamber 
(hemocytometer) in the presence of trypan blue stain. Since trypan blue is a vital dye 
and can leak into cells that have damaged cell membrane, viable cells exclude the 
dye while dead cells are stained dark blue in color (McAteer & Davis, 1994). 
Besides, Coulter counter is also a widely used device for counting cells. In this 
method, cells drawn through a fine orifice increase the electrical impedance to the 
current flowing and produce a series of pulses that are sorted and counted (McAteer 
& Davis, 1994). 
Other than direct cell count, colorimetric method including MTT assay and 
measurement of LDH activity was also applied for cell quantification and 
cytotoxicity respectively. In 1983, Mosmann described a rapid colorimetric assay for 
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the measurements of cell growth. The assay is based on the cleavage of the yellow 
water-soluble substrate 3-(4,5,-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) into a water insoluble dark blue formazan product by mitochondrial 
dehydrogenase enzymes in living cells (Mosmann, 1983). The amount of formazan 
produced is directly proportional to the cell number (Gerlier & Thomasset, 1986). In 
addition, the cytotoxity can be assessed by LDH activity as well. This assay is based 
on the measurement of lactate dehydrogenase (LDH) activity released from the 
cytosol of damaged cells into the supernatant. The LDH activity can be measured 
colorimetrically in an enzymatic test. 
Apart from colorimetric method, [^H]-thymidine incorporation is one of the 
most traditional methods for quantifying cell proliferation. Since chromosome 
replication is accompanied by the incorporation of soluble nucleotide precursor into 
newly synthesized DNA in the S phase in cell cycle, the monitoring of DNA 
synthesis is another indirect parameter of cell proliferation. In this method, dividing 
cells are pulsed with radioactive exogenous precursor [^H]-thymidine, the amount of 
radioactivity incorporated into the cell DNA is determined by harvesting the cells on 
a glass-fiber filter followed by liquid scintillation counting. Due to the potential 
hazards associated with the use of radioactive substances, non-radioactive method 
alternative to the [^H]-thymidine incorportion was developed (Takeuoshi et al” 
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2001). [^H]-thymidine is replaced by 5-bromo-2‘-deoxyurdine (BrdU) in this method 
and it is based on the incorporation of the pyrimidine analogue BrdU instead of 
thymidine into the DNA of proliferating cells. 
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2.6 Cell Cycle Regulation 
In eukaryotic cells, the cell cycle consists of a series of stages, termed Gi, S, Gi 
and M，in which cells have to pass through consecutively. The principal task of the 
cell cycle is to duplicate chromosomal DNA precisely during S phase and to 
segregate it into two identical progeny during M phase (mitosis). Besides, Gi and G2 
phases are between S and M phases. Gi phase is a period distinguished by cell 
growth, and G2 phase has been described as an interval in which the cells prepare for 
division (Becker et al., 2000; Sherr et al., 2000). 
Located between Gi and S, G2 and M phases are two checkpoints, Gi 
(restriction point) and G2 checkpoint. These checkpoints are the preparatory periods 
during which the cell is growing and/or synthesizing the factor required during S and 
M phases respectively. They are responsible for checking the specific activities, such 
as the growth in cell size or DNA replication, which have to be carried out properly 
during the phase before the checkpoint. If there are any improper activities, the cell 
cycle will stop at these checkpoints temporarily and amends any possible errors, or 
the cell will withdraw from the cell cycle into a quiescent state, Go phase (Becker et 
al., 2000). 
Generally, the cell cycle control is provided by a family of serine/threonine 
protein kinase complexes consisting of a catalytic subunit, a cyclin dependent kinase 
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(cdk); and a regulatory subimit, cyclin (Norbury & Nurse, 1992). And the cyclin-cdk 
activity is regulated by the availability of cyclin subunit, state of phosphorylation of 
cyclin-cdk complex and two groups of cdk inhibitors (INK4 and Cip/Kip families) 
(Molinari, 2000). 
Cdks subunits by themselves are inactive, and binding of cdk subunit to a cyclin 
protein is required for their activity as well as their regulation. These complexes 
undergo changes in the kinase and cyclin components that are believed to drive the 
cell from one stage of the cell cycle to another. D type cyclins with cdk4 or cdk6, 
cyclin E with cdk2, cyclin A with cdk2 and cyclin B with cdkl are responsible for 
the progression through Gl, Gl/S, S and G2/M phase of the cell cycle respectively 
(Zetterberg, 1996). 
Apart from the cyclin, cyclin dependent kinase and cyclin dependent kinase 
inhibitor, tumor suppressor proteins are also involved in cell cycle regulation, for 
examples, the Rb and p53 proteins. 
Rb protein with a molecular weight of 105 kDa is encoded by Rb gene that is 
the first tumor suppressor gene to be identified in hereditary retinoblastoma (RB). 
Besides, Rb is a component of Gl signaling pathway and the role of Rb is to control 
the transition from Gl into S phase (Weingberg, 1995). In its hypophosphorylated 
state, Rb prevents progression from Gl to S phase by binding with members of the 
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E2F transcription factor family. The binding of Rb with the transcription factor E2Fs 
(including E2F1, 2 and 3) not only blocks transcription activation by E2F but also 
actively represses transcription by recruiting histone deacetylase to the promoter of 
genes required for S phase entry (Brehm et al., 1998). 
On the other hand, p53, which is also a tumor suppressor protein, regulate the 
cell cycle by determining either cell cycle to arrest, allowing the repair of damaged 
DNA, or to undergo programmed cell death (apoptosis). When the genome suffers 
damage that cannot be repaired, p53 would mediate an apoptotic response that 
eliminates the threat of the deregulated cell. But if the damage is not severe, p53 can 
induce production of a cyclin dependent kinase inhibitor p21, thereby obstructing 
cyclin D- and cyclin E-cdk activity, and halting the cells at the G1 restriction point 
for DNA repair (Becker et al, 2000). 
Defects in the cell cycle regulatory mechanism such as uncontrolled cell 
proliferation, decreased cellular differentiation, ability to invade surrounding tissue, 
and ability to establish new growth at ectopic sites (metastasis) are the properties of 
cancer cells that are different from normal cells. For example, leukemia arises as 
uncontrolled proliferation that occurs in hematopoietic cells. As such, it seems that 
the effect of some antitumor agents may contribute by restoration of cell cycle 









































































































































































































































In a recent study, Connor et al. (2001) demonstrated the Gi cell cycle arrest 
after the treatment of ceramide in the leukemic cell lines. The result obtained from 
Western blotting analysis revealed that Rb might play a key role as the effector of 
ceramide signaling, since Rb activation (appearance of hypophosphorylated forms of 
Rb) was observed in the ceramide responsive cells. Therefore, it illustrated that 
ceramide is a key regulator of cellular proliferation by preventing progression of 
leukemia cell from Gi to S phase (Connor et al., 2001). 
Besides, a natural product Bu-Zhong-Yi-Qi-Tang (BZYQT), which was 
extracted from a formulation of ten Chinese medicinal herbs, inhibited proliferation 
of three of the human hepatoma cell lines, including Hep3B, HepG2 and HA22T. 
The I C 5 0 of BZYQT on Hep3B, HepG2 and HA22T are 432.5, 455.4 and 2284.3 
|Lig/ml respectively. Besides, in the analysis of cell cycle by using flow cytometry and 
gel electrophoresis of fragmentation DNA，apoptotic (sub-Gi) peak in the DNA 
histogram and DNA fragmentation in a ladder pattern were observed in Hep3B cell 
lines. The result illustrated the ability of BZYQT in inhibiting cell cycle progression 
in hepatoma cells followed by apoptosis (Kao et al” 2001). 
In addition to BZYQT, magnolol, which is a hydroxylated biphenyl compound, 
suppressed human colon (COLO-205) and liver cancer (Hep-G2) cells in vitro as 
well. Magnolol was extracted from a widely used Chinese herbal medicine Magnolia 
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officinalis. Similar as that of BZYQT, magnolol treated COLO-205 and Hep-G2 
cells displayed the DNA ladder patterns in the DNA gel electrophoresis. Moreover, 
magnolol inhibited [^H] thymidine incorporation during the S phase of the cell cycle 
as well (Lin et al； 2002). 
Although the mechanism has not been well studied, higher Basidiomycetes 
mushrooms were shown to have anti-proliferative activity on leukemia cells in vitro. 
The suppressive effect of Ganoderma lucidum Karst compound (GLC) on K-562 
proliferation is not only in a dose-dependent (from 4 to 20 mg/ml) but also in a 
time-dependent manner (from 1 to 5 days) (Zhong et al., 1999). 
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Chapter 3 
Materials and Methods 
3.1 Extraction 
3.1.1 Extraction of Dictyophora indusiata Polysaccharides 
Dried fruit bodies of Dictyophora indusiata were purchased from local market 
(Fig. 3.1). After being soaked and washed with 2 liters of distilled water, the fruit 
bodies (200 g) were disintegrated with a blender and extracted with hot water in a 
slow cooker for 2-3 hours. The water extracts were percolated with gauze and the 
residues were boiled again with 2 more liters of distilled water. This hot water 
extraction was repeated for 2 more times, and each time last for 2 to 3 h as before. 
The water extracts obtained were pooled and centrifuged at 22,095 g for 30 min with 
a J2-MI centrifuge (Beckman, USA) and a JA-14 rotor to remove water-insoluble 
components. The collected supernatant of the extracts was concentrated by rotary 
evaporator (BUCHI Rotavapor R-200, Switzerland) and precipitated by 40% ethanol 
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to obtain the relatively higher molecular weight polysaccharides. The relatively 
lower molecular weight polysaccharides were obtained by 80% ethanol precipitation. 
To allow more times for complete precipitation, the extracts were kept overnight at 
4°C. The precipitates formed from these two ethanol precipitations were collected by 
centrifugation at 22,095 g for 30 min. The pellets were re-dissolved in distilled water 
and lyophilized. The two lyophilized products obtained from 40% and 80% ethanol 
precipitations were designated as DI2 and DIB fractions, respectively. 
3.1.2 Purification of Dictyophora indusiata Polysaccharides 
3.1.2.1 Preparation of DEAE-cellulose Ion Exchanger 
DEAE-cellulose resin (Sigma, USA) was suspended in distilled water and left 
to swell overnight at 4°C. The resin was first treated in 2 volumes of 0.4 N HCl 
solution for 30 min. After discharging the HCl solution, the resin was washed with 
distilled water until pH was close to 7.0. The resin was further treated in 2 volumes 
of 0.4 N NaOH for 30 min. After discharging the NaOH solution, the resin was also 
washed with distilled water until the pH was near to 7.0. 
3.1.2.2 Fractionation 
Fifty miligrams of crude DI3 polysaccharides dissolved in distilled water was 
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applied onto a DEAE anion exchange cellulose column [2.5 cm (LD.) x 30 cm (L)]. 
The column was first washed with distilled water to elute the unbound 
polysaccharides, which were designated as DBa fraction. The retained components 
were then eluted with a linear gradient of sodium chloride solution ranging from 0 to 
1.0 M. Fractions of 5 ml/tube were collected at a flow rate of 20 ml/hr. Presence of 
polysaccharides in each tube was determined by phenol-sulfuric assay (Dubois et al., 
1956). The concentration of sodium chloride solution, which was used to elute the 
retained polysaccharides, was calculated by the following equation: 
Volume eluted by particular concentration of NaCl solution 
C = l + l x  
Total volume eluted 
The retained components, which were eluted by the concentrations of 0.04 M 
and 0.5 M NaCl solutions, were designated as DI3b and DI3c fractions, respectively. 
Desalting of DI3 fractions was performed by dialysis (Spectra/Por®, MWCO: 
12-14,000) against distilled water at 4°C. The remaining solution was then 
lyophilized. A simplified flow chart illustrating the procedures of extraction and 
purification of the polysaccharides is shown in Fig. 3.2. 
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Fig. 3.1 Dried fruit bodies of Dicytophora indusiata purchased from local market. 
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200 g Dried fruit bodies of Dictyophora indusiata 
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Repeated hot water extraction in a slow cooker 
(2 L distilled water, 2-3 h, 3 times) 
Supernatant 
Concentrated at 60�C by rotary evaporator 
Precipitate with ethanol up to 40% final concentration 
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Fig. 3.2 A simplified flow chart showing the extraction and purification of 
Dictyophora indusiata polysaccharides. 
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3.2 Characterization of Dicytophora indusiata Polysaccharides 
3.2.1 Polysaccharide Content Determination 
Contents of polysaccharides in DI and DI3 fractions were determined by Phenol 
sulfuric assay (Dubois et al； 1956; Scherz & Bonn, 1998). Reactions of 
polysaccharides with phenols, in the presence of sulfuric acid, are universal, and are 
suitable for both neutral and acidic polysaccharides. 
In this study, 0.2 ml of 5% phenol solution was added to 0.2 ml of 100 \ig/m\ 
aqueous sample (both of them were dissolved in distilled water). A blank control, 
which consisted of distilled water only, and a standard curve of D-glucose (Ajax) 
ranging from 0-70 |xg/ml, were also prepared. 1 ml of concentrated sulfuric acid 
(98.8 %) was added carefully to the surface of the solution, and the mixture was 
allowed to stand for 10 min at room temperature. After intensive vortexing, the 
mixture was allowed to stand for another 30 min at room temperature. The resultant 
solution was orange-red in color, and its absorbance, against the blank control, was 
measured at wavelength 490nm with a microplate reader (SPECTRAmax 250). 
3.2.2 Protein Content Determination 
Content of proteins in DI3 fraction was determined by Lowry-Folin method 
(Lowry et al., 1951; Waterborg & Matthews, 1994), which was based on both the 
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Biuret and Folin-Ciocalteau reaction. 
In this study, 0.1 ml 2 N NaOH solution was added to 0.1 ml of 1 mg/ml 
aqueous sample (both of them were dissolved in distilled water). A blank control, 
which consisted of distilled water only, and a standard curve of bovine serum 
albumin (Sigma) ranging from 0-500 jiig/ml were also prepared. The mixture was 
hydrolyzed at 100°C for 10 min in a heating block. After cooling to room 
temperature, 1 ml of freshly mixed complex-forming reagent, which was prepared by 
mixing 2% NaiCOs, 1% CuSCU SHiO and 2% sodium potassium tartrate (w/v) in 
distilled water in a volume ratio of 100:1:1, was added to the mixture. After standing 
for 10 min at room temperature, 0.1 ml of Folin-Ciocalteu's phenol reagent (BDH) 
was added to the solution. The mixture was then allowed to stand for 30 min at room 
temperature. The absorbance of the solution was then measured at wavelength 750 
run with the microplate reader. 
3.2.3 Gas Chromatography (GC) 
DI3 fraction was subjected to Gas Chromatography (GC) to determine the 
composition of neutral monosaccharides. About 13 mg of the sample was 
hydrolyzed with 0.7 ml 12 M sulfuric acid at 35°C for 1 h with constant stirring. 
The hydrolysate was then diluted to 2 M sulfuric acid with 3.5 ml distilled water, and 
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boiled in a water bath with continuous shaking for 1 h. After cooling to room 
temperature, 3 ml of the hydrolysate was used to prepare alditol acetates of neutral 
and amino sugars according to the method described by Blankeney et al. (1983). The 
remaining hydrolysate was reserved for uronic acid determination in Section 3.2.4. 
3-D-allose (1 mg/ml) was added into the hydrolysate as an internal standard. 1.25 ml 
ammonia (12 M) and 5 octan-2-ol was added to neutralize the hydrolysate and 
prevent foam forming, respectively. The hydrolysate was then reduced by adding 0.2 
ml freshly prepared sodium borontetrahydride (200 mg/ml) and incubating in 4ffC 
water bath for 30 min. 0.1 ml glacial acetic acid was added to stop the reducing 
reaction, which was followed by 2 ml acetic acid anhydride and 0.3 ml 
1-methylimidazole. The mixture was vortexed and left at room temperature for 10 
min. 5 ml distilled water was then added to dissolve the excess acetic anhydride. 
After adding 1 ml dichloromethane, the mixture was allowed to stand for 10 min for 
phase separation. While the top aqueous layer was removed, the bottom organic 
layer was washed twice each with 2 ml distilled water. Anhydrous sodium sulphate 
was then added to dehydrate the layer. The obtained sample solution was then stored 
in a vial at -20°C prior to use. Determination of neutral sugar with GC was 
performed with HP6890 gas chromatography using an Alltech DB-225 capillary 
column [15 m (L) x 0.25 mm (LD.), 0.25 jum film thickness]. The oven temperature 
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program was given as follows: initial temperature, 180°C with 4°C /min rise to 
220°C and held at 220°C for 30 min. Helium was used as the carrier gas in the set up. 
2 |xl sample was injected into the column and the neutral sugar in the sample was 
detected by flame ionization. The amount of monosaccharides present in each 
sample was expressed as proportion by weight (%w/w). 
3.2.4 Uronic Acid Content Determination 
The content of uronic acid was determined by colorimetric method according to 
the Officical Methods of Analysis (45.4.11) (AOAC, 1996). Hydrolysate obtained 
from acid depolymerization was used for determination. 300 |li1 of boric acid-sodium 
chloride solution (2% sodium chloride and 3% boric acid in distilled water) was 
added to an aliquot of 300 |LI1 hydrolysate in a test tube and mixed thoroughly. A 
blank control consisting of sulfuric acid (2 M) and D-galacturonic acid monohydrate 
standards (10, 50, 100, 200, 500 jiig/ml) were prepared, respectively. 5 ml 
concentrated sulfuric acid (12 M) was added to the mixture with vortexing, which 
was then kept at 70°C for 40 min. After the mixture was cooled to room temperature, 
200 |il of dimethyphenol (0.1% 3,5-dimethyphenol in glacial acetic acid) was added 
and vortexed thoroughly for 5 min. The mixture was then stood at room temperature 
for 15 min. Absorbance of the samples solutions were measured against blank at 400 
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and 450 nm, respectively. Readings at 400 nm were subtracted from those at 450 run 
to correct any interference from hexoses. The uronic acid content was determined 
using D-galacturonic acid monohydrate as standard, and expressed as a 
polysaccharides residue by multiplying a factor of 0.83. The uronic acid content 
present in each sample was expressed as proportion by weight (%w/w). 
3.2.5 High Performance Liquid Chromatography (HPLC) 
Purity and molecular weight of DI3 fraction were determined by analytical 
High Performance Liquid Chromatography (HPLC). Samples (10 jig) were dissolved 
in 0.5 M NaCl solution and filtered through a 0.22 \im filter. HPLC was carried out 
using Hewlett Packard series 1100 HPLC system equipped with a TSK gel™ colunm 
G5000PW [30 cm (L) x 7.5 mm (LD.), particle size: 17 |Lim] (SUPELCO). DI3 
fraction was eluted using 0.5 M NaCl at a flow rate of 0.5 ml/min at 25�C, and 
detected with Refractive Index detector (HP 1047A RI Detector). Dextran standards 
of molecular weight 1, 5，25, 80, 270 and 670 kDa, respectively, were used for 
estimating the molecular weight of polysaccharides in the sample. 
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3.3 In vivo Studies 
3.3.1 Animals 
Male BALB/c mice (8-9 weeks) were used in this study. All the mice were 
supplied by the Laboratory Animal Service Centre (LASEC) of The Chinese 
University of Hong Kong. The animals were housed in the Animal House of 
Department of Biology (CUHK) under the normal laboratory conditions (21 士 2°C, 
12/12 h light/dark cycle). They were freely accessible to tap water, and maintained 
on standard rodent chow. All the mice were allowed to acclimatize for a week before 
each experiment. 
3.3.2 Maintenance of Sarcoma 180 Cell Line 
Sarcoma-180 cell line in ascitic form was maintained in male BALB/c mouse 
peritoneum, and was passed to another mouse at every seventh day. After the mouse 
was killed by cervical dislocation, the Sarcoma 180 cells in ascitic fluid were 
collected by lavage of peritoneal cavity with sterile PBS. The cells were then washed 
twice and resuspended in sterile PBS. The viable cells were counted by 
hemocytometer and Trypan blue exclusion method. After adjusting the cell density 
to 2.5x10^ cells/ml by sterile PBS, 0.2 ml of Sarcoma 180 cells suspension (i.e. 
5x10^ cells/0.2 ml) was passed to another mouse (i.p.). 
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3.3.3 Effect of DI3 Fraction on Sarcoma 180 Solid Tumor (Ohno et al, 1984) 
The antitumor effect of DI3 fraction was studied in vivo using male BALB/c 
mice (-20-25 g). At the beginning of the experiment, a suspension of Sarcoma-180 
cells was prepared as described in Section 3.3.2 After anesthetization of the mice, 
initial body weight of each mouse was recorded, and 0.2 ml of Sarcoma-180 cells 
were inoculated subcutaneously onto the back of each mouse. Three days after 
inoculation, the tumor-bearing mice were separated into groups and caged randomly. 
DI3 fraction was dissolved in PBS at different doses, and was administered to the 
tumor-bearing mice for 10 consecutive days (i.p.). Control group with tumor-bearing 
mice was given sterile PBS only. Another control group, which was neither 
implanted with tumor cells nor received peritoneal injection of samples, was also 
setup to monitor the weight change of normal mice. Twenty-one days after 
inoculation, the mice were sacrificed by cervical dislocation. The final body weight 
and tumor weight of each mouse were recorded. The change in body weight and 
tumor inhibition were calculated by the following equations: 
Percentage change in body weight (%) 
Average (final body weight - initial body weight) 
= X 100 % 
Average Initial body weight 
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7-8 weeks male BALB/c mice 
i 
Acclimatize for a week 
Day 0 1. Anesthetize the mice by diethyl ether 
2. Record the initial weight 
3• Inoculate S-180 tumor cells (5x10^ cells/0.2 ml) 
onto the back of mice (s.c.) 
i 
Day 3 to 12 Administration of samples / PBS for 10 consecutive days (i.p.) 
少 
Day 21 1 • Sacrifice the mice by cervical dislocation 
2. Enucleate the tumor from the mice 
3. Record the tumor and final body weights 
Fig. 3.3 A flow chart showing the steps for studying the in vivo antitumor 
effect of the polysaccharides. 
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Percentage of tumor inhibition (%) 
r 
Average tumor weight of treatment group 
= 1 X 1 0 0 % 
Average tumor weight of control group 
V J 
A simplified flow chart illustrating the steps and procedures for studying the 
antitumor effect of DI3 is shown in Fig. 3.3. 
3.3.4 Effect of DBc Fraction on Tumor Necrosis Factor-Alpha (TNF-a) and 
Interleukin 2 (IL-2) Production (Ohno et al., 1995) 
3.3.4.1 Treatment of Mice 
BALB/c mice (8-9 week old) were used in this experiment. They were divided 
randomly into four groups. One of them received 12.5 mg/kg DBc in sterile PBS for 
5 consecutive days, and another group received sterile PBS only (i.p.). After 5 days 
of injection, each mouse of these two groups was given 10 |Lig LPS (Sigma) in 0.2 ml 
PBS (i.v.). The other two groups received either 12.5 mg/kg DBc or PBS only for 5 
consecutive days (i.p.). 
3.3.4.2 Preparation of Mouse Serum 
Mouse blood was obtained by eye puncture 1 hour after LPS administration, 
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and was allowed to clot at 4°C for 1 hour. The collected blood was then centrifuged 
for 10 min at 1000 g with a Jouan A-14 centrifuge, and the supernatant was collected 
as serum for TNF-a and IL-2 assays, respectively. 
3.3.4.3 Enzyme-linked Immunosorbent Assay (ELISA) for TNF-a Production 
TNF-a in the serum sample was determined by a sandwich ELISA kit, 
OptEIA™ Set Mouse TNF-a (Mono/Poly) (PharMingen). All the steps and 
procedures were followed as those stated in the manual of the kit. In brief, 100 |LI1 per 
well of anti-mouse TNF-a monoclonal antibody diluted in coating buffer (0.1 M 
sodium carbonate, pH 9.5) was bound to the surface of 96 well, flat bottom plates 
(96-well Nunc Maxisorp) by incubating at 4 � C overnight. The plate was aspirated 
and washed for 5 times with phosphate buffered saline (PBS) containing 0.05% 
Tween 20 (washing buffer), and blocked with 200 |LI1 assay diluent (provided) at 
room temperature for 1 hour. After 5 times of aspirating and washing with washing 
buffer, the plate was sealed and incubated with 100 |LI1 diluted recombinant mouse 
TNF-a in assay diluent or samples at room temperature for 2 hours. The plate was 
then washed 5 times with washing buffer, and was then treated with 100 [il diluted 
biotinylated anti-mouse TNF-a polyclonal antibody in assay diluent. After 1 hour of 
incubation, the plate was aspirated and washed 5 times with washing buffer, which 
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was then treated with 100 jil diluted enzyme reagent (avidin-horseradish peroxidase 
conjugate). After washing the wells for 7 times with the washing buffer to remove 
any unbound antibody, presence of the peroxidase-conjugated antibody was detected 
by the addition of 100 \i\ TMB (3,3',5,5'-tetramethylbenzidine) substrate reagent 
(provided), and incubated for 30 min at room temperature. Color development was 
stopped by the addition of 50 |LI1 2 N sulfuric acid, and the absorbance of each well at 
450 nm was determined by the microplate reader with a reference wavelength of at 
570 nm. A standard calibration curve was also prepared using recombinant mouse 
TNF-a in this study. 
3.3.4.4 Enzyme-linked Immunosorbent Assay (ELISA) for IL-2 Production 
IL-2 in the serum sample was determined by a sandwich ELISA kit, OptEIA™ 
Set Mouse IL-2 (Mono/Poly) (PharMingen). All the steps and procedures were 
followed as those stated in the manual of the kit. In brief, 100 |xl per well of 
anti-mouse IL-2 monoclonal antibody diluted in coating buffer (0.1 M sodium 
carbonate, pH 9.5) was bound to the surface of 96 well, flat bottom plates (96-well 
Nunc Maxisorp) by incubating at 4 � C overnight. The plate was aspirated and washed 
for 5 times with phosphate buffered saline (PBS) containing 0.05% Tween 20 
(washing buffer), and blocked with 200 |LI1 assay diluent (provided) at room 
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temperature for 1 hour. After 5 times of aspirating and washing with washing buffer, 
the plate was sealed and incubated with 100 |LI1 diluted recombinant mouse IL-2 in 
assay diluent or samples at room temperature for 2 hours. The plate was then washed 
5 times with washing buffer, and was then treated with 100 |LI1 diluted biotinylated 
anti-mouse TNF-a polyclonal antibody in assay diluent. After 1 hour of incubation, 
the plate was aspirated and washed 5 times with washing buffer, which was then 
treated with 100 jiil diluted enzyme reagent (avidin-horseradish peroxidase 
conjugate). After washing the wells for 7 times with the washing buffer to remove 
any unbound antibody, presence of the peroxidase-conjugated antibody was detected 
by the addition of 100 |xl TMB (3,3',5,5'-tetramethylbenzidine) substrate reagent 
(provided), and incubated for 30 min at room temperature. Color development was 
stopped by the addition of 50 |LI1 2 N sulfuric acid, and the absorbance of each well at 
450 run was determined by the microplate reader with a reference wavelength of at 
570 nm. A standard calibration curve was also prepared using recombinant mouse 
IL-2 in this study. 
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3.4 In vitro Studies 
3.4.1 Maintenance of Cell Lines 
Three human cell lines (acute promyelocytic leukemia HL-60, chronic 
myelogenous leukemia K-562 and liver cancer HepG2) and one murine 
Sarcoma-180 (S-180) cell line were used to study the antiproliferative and cytotoxic 
effect of DI3 fraction in this study. All the cell lines were provided by American 
Type Culture Collection (ATCC) (Rockville, MD). The human cell lines were grown, 
in RPMI 1640 medium (Sigma), supplemented with 0.2% sodium bicarbonate 
(Sigma), 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 |ig/ml of 
streptomycin and 0.25 |xg/ml amphotericin B (all from GIBCOBRL). The S-180 cell 
line was grown in Dulbecco's Modified Eagle's Medium (DMEM) (GIBCOBRL), 
supplemented with 0.37% sodium bicarbonate, 10% heat-inactivated fetal bovine 
serum, 100 U/ml penicillin, 100 |Lig/ml of streptomycin and 0.25 jiig/ml amphotericin 
B. A monkey kidney Vero cell line was also used in the toxicity test, which was also 
provided by ATCC. The cells were grown in Minimal Essential Medium (MEM) 
(GIBCOBRL), supplemented with 10% heat-inactivated fetal bovine serum, 100 
U/ml penicillin, 100 iig/ml of streptomycin and 0.25 |Lig/ml amphotericin B in the 
presence of 20 mM Hepes, 2 mM of glutamine and 0.024 mg/ml gentamycin. All the 
cells were maintained under a fully humidified atmosphere of 95% room air and 5% 
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CO2 at 37�C in 25 cm^ sterile polystyrene tissue culture flasks (Sarstedt). The 
medium was replaced three times a week, and cell density and viability were 
routinely monitored by hemocytometer and Trypan Blue exclusion method (detailed 
in Section 3.4.4). 
3.4.2 Cytotoxicity on Cancer Cell Lines 
HL-60, K-562 and S-180 cells were seeded, especially, in 96-well round bottom 
culture plates (IWAKI) at an initial density of 5 x 10^  cells per 100 |xl (i.e. 5 x 10^  
cells/ml), HepG2 cells were seeded in 96-well flat bottom culture plates (IWAKI) at 
a an initial density of 2 X 10^ cells per 200 |LI1 (i.e. 1 X 10^ cells/ml). Each of cells 
was incubated, respectively, with 100, 200, 400 and 800 |ig/ml of DI3 fractions for 
72 hours. The cytotoxic effects of DB fraction on HL-60, K-562 and S-180 cells 
were determined by Trypan blue exclusion assay. The cytotoxic effects of DI3 
fractions on HepG2 cells were measured by MTT assay. 
3.4.3 Cytotoxicity on Normal Cell Line 
Vero cells were seeded in a 96-well flat bottom culture plate at an initial density 
of 2 X lo4 cells per 200 jul (i.e. 1 x 10^  cells/ml). DI3 fraction at concentrations of 
250，500 and 1000 |Lig/ml were incubated, respectively, with the cells for 72 hours. 
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The toxicity was measured by MTT assay. 
3.4.4 Trypan Blue Exclusion Method 
Effect of DI3 fraction on proliferation of HL-60, K-562 and S-180 were 
determined by counting the cell number with hemocytometer. In meanwhile, the cell 
viability was examined by Trypan blue exclusion method. After incubating with 
different concentrations of DI3 fractions, 100 \i\ of 0.4% Trypan blue solution in 
PBS (w/v) was added to each well. The total number of cells and the trypan 
blue-stained cells in the four 1-mm^ comers of the hemocytometer were counted. 
The cell density and viability were calculated by the following equations: 
The total cell number in 
the four 1-mm comers 
Cell density x Dilution factor x lO* cells/ml 
4 
Viable cell count 
Viability (%) = X 100% 
Total cell count 
In order to determine the I C 5 0 of DB fractions on different cancer cell lines, the 
percentage of inhibition was also expressed by following equation: 
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r -N 
Average cell density in treatment group 
1 X 100% 
Average cell density in control group 
� J 
3.4.5 MTT Assay 
The cytotoxic effects of DI3 fraction on HepG2 and Vero cell lines were 
determined by MTT assay (Mosmann, 1983). After incubating with DI3 fractions, 
MTT solution was freshly prepared by dissolving MTT 
(3-(4,5,-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (Sigma) in filtered 
PBS at 5 mg/ml. 20 of the MTT solution was added to each well. After 5 hours of 
incubation, the medium was removed and the blue formazan formed was dissolved 
by adding 150 jiil of acidic isopropanol (0.04 N HCl). All the wells were then mixed 
by pipetting until all crystals were dissolved completely. Absorbance of the blue 
formazan solution generated was measured at 570 nm by the microplate reader. The 
percentage of inhibition was expressed by the following equation: 
r ^ 
Average absorbance of treatment group 
1- X 100% 
Average absorbance of control group 
� J 
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3.4.6 BrdU Incorporation (Takeyoshi et al., 2001) 
Besides counting the cell number, effect of DI3b fraction on proliferation of 
HL-60 cells was further determined using the cell proliferation assay kit (Roche). 
HL-60 cells were seeded in a 96-well flat-blottom microplate at 5 x lo"^  cells/ml, and 
were incubated with 100，200, 400 and 800 jiig/ml of DI3 fractions, respectively, for 
72 hours. After incubation of 10 jul BrdU labeling solution (provided) was added to 
each well and incubated at 37°C for 2 h. After centrifugation by Centra MP4R (lEC) 
at 300 g for 10 min, the supernatant were removed, and the plate was aspirated for 
15 min. 200 |LI1 of Fix-Denat solution (provided) was added to each well to fix the 
cells, and the plate was allowed to stand for 30 min at room temperature. After 
removing the Fix-Denant solution, the diluted anti-BrdU-POD working solution 
(provided) was added to each well and incubated for 90 min. After rinsing three 
times with the provided washing buffer, 100 ]LI1 of substrate solution was added and 
allowed to react for 15 min at room temperature. Absorbance at 370 nm was 
determined with a microplate reader at a reference wavelength at 492 nm. 
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3.5 Statistical Analysis 
Results were expressed as mean 土 standard deviation (S.D.) and analyzed by 





4.1 Extraction and Fractionation of Polysaccharides from Dicytophora indusiata 
4.1.1 Percentage Yield of Crude DI Polysaccharides 
After hot water extraction, 3.1 g DI2 and 10.1 g DI3 were obtained from 200 g 
of dried fruit bodies of mushroom Dicytophora indusiata with 40% and 80% ethanol 
precipitation, respectively. The total percentage yield of crude DI polysaccharides 
was 6.6 % (Table 4.1). 
4.1.2 Percentage Yield of DI3 Fractions 
To further fractionate crude DI3 polysaccharides, 50 mg of DI3 was applied 
onto a DEAE-cellulose column. After eluted by distilled water, 0.04 M and 0.5 M 
NaCl, polysaccharides fractions designated as DBa (34.7 mg), DI3b (4.6 mg) and 
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Results 
Weight (g) Yield (%) 
Dried fruit bodies 200 ---
DI2 3.1 1.55 
DI3 10.1 5.05 
Table. 4.1 Yields of different polysaccharide fractions from 200 g of dried fruit bodies of 
Dictyophora indusiata. 
DI2 polysaccharides were obtained from ethanol precipitation up to 40% final 
concentration. 

















































































































































































































































































































Weight (mg) Yield (%) 
DI3 50 - -
DI3a 34.7 69.4 
DBb 4.6 9.2 
DBc 5.5 11.0 
Recovery 44.8 89.6 
Table. 4.2 Yields of different polysaccharide fractions from 50 mg of DI3 polysaccharide 
fraction in DEAE-cellulose column. 
DI3 polysaccharides were obtained from ethanol precipitation up to 80% final 
concentration. 
DBa, DBb and DBc fractions were eluted by distilled water, 0.04 M and 0.5 M 
NaCl solution, respectively, from the DEAE-cellulose column. 
The collected freeze-dried DI3 fractions were weighed after desalting by 
dialysis. 
Total weight of DI3 fractions 
Recovery (%) = x 100 % 
Weight of crude DI3 polysaccharides 
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4.2 Characterization of DI3 Fractions 
4.2.1 Polysaccharide and Protein Contents of DI3 Fractions 
Contents of polysaccharides and proteins were determined by phenol sulfuric 
acid assay and Lowry-Folin method, respectively (Table 4.3). Each mg of the crude 
DI3 polysaccharides contained 0.64 mg of polysaccharides and 0.12 mg of proteins. 
Among the three fractions, DI3a contained the highest amount of polysaccharides 
(0.94 mg per mg of sample), and DBc contained the highest amount of proteins 
(0.25 mg per mg of sample). 
4.2.2 Relative Monosaccharide and Uronic Acid Content in Different DI3 
Fractions 
The relative monosaccharide and uronic acid content in different DI3 fractions 
were determined by gas chromatography and colorimetric method, respectively. As 
shown in Table 4.4, DI3 fractions were mainly composed of monosaccharide, 
including mannose, glucose, galactose and uronic acid. Trace amounts of xylose 
were also found in DI3, DBb and DBc fractions. Among the three DI3 fractions, 
mannose constituted the highest amount in DI3a (16.84 %) and DBb (19.96 %) 
fractions, while glucose constituted the highest amount in DBc fractions (19.31 %). 
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Methods used Lowry-Folin method Phenol-sulfuric assay 
Proteins contents (%) Polysaccharides contents (%) 
DI3 12 ±0.6 64 ± 2 
DI3a 3 ± 0.3 94 土 2 
DI3b 10 ±0.6 88 ±4 
DBc 25 士 0.5 72 士 1 
Table. 4.3 Protein and polysaccharide contents in DI3 polysaccharides and different 
DI3 fractions. 
Protein and polysaccharide contents were determined by Lowry-Folin 
method and Phenol-sulfuric assay, respectively. 




Proportions (% w / w ) ^ 
Monosaccharides — 
DB DBa DBb DBc 
Fucose N.D. N.D. N.D. N.D. 
Galactose 1.03 1.72 1.70 0.89 
Glucose 7.86 4.71 10.40 19.31 
Mannose 13.34 16.84 19.96 4.19 
Xylose T N.D. T T 
Arabinose N.D. N.D. N.D. N.D. 
Ribose N.D. N.D. N.D. N.D. 
Rhamnose N.D. N.D. N.D. N.D. 
Uronic acid 2.75 0.03 1.21 17.09 
Table. 4.4 Proportions of different monosaccharides and uronic acid in crude DB 
polysaccharides and different DB fractions determined by gas 
chromatograpy. 
a Results are expressed as relative proportions (% w/w) in each sample. 
"N.D." indicates that the particular monosaccharide was not detectable. 
"T" indicates that only trace amount of monosaccharide was detected. 
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4.2.3 Estimated Molecular Weight of DI3 Fractions 
Gel permeations of the DI3a, DI3b and DBc fractions are shown in Fig. 4.2, 
‘ 4.3 and 4.4, respectively. A non-polysaccharides peak was appeared in the elution 
curves of DI3 fractions and dextran standards, at a retention time of about 25.5 min. 
The molecular weight of different compounds in different DB fractions were 
determined by measuring their retention times and compared them to the dextran 
standard (Fig. 4.5). 
DBc is a relatively homogenous polysaccharide fraction, and the average 
molecular weight was about 3.3 kDa (Fig. 4.4). Both DI3a and DI3b fraction 
contained more than one group of polysaccharides. DI3a fraction contained two 
groups of polysaccharides and the average molecular weight were determined to be 
17 kDa and 284 kDa, respectively (Fig. 4.2). DI3b fraction contained three groups of 
polysaccharides, and their average molecular weights were 2.5 kDa, 12 kDa and 
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Fig. 4.2 Gel permeation of DI3a fraction. 
Molecular weight of DI3a fraction was determined by HPLC using 
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Fig. 4.3 Gel permeation of DI3b fraction. 
Molecular weight of DI3b fraction was determined by HPLC using 
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Fig. 4.4 Gel permeation of DBc fraction by HPLC. 
Molecular weight of DBc fraction was determined by HPLC using 
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Fig. 4.5 HPLC determinations of molecular weights of different DI3 fractions using 
dextran standards of 1, 5, 25, 80, 270 and 670 kDa. 
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4.3 Antitumor Effect of Dictyophora indusiata polysaccharides In vivo 
4.3.1 In vivo Antitumor Effect of Crude DI Polysaccharides 
The crude DI polysaccharides were administered to Sarcoma-180 solid 
tumor-bearing mice to study the in vivo antitumor activity. Both DI2 and DB 
fractions were administered, respectively, 72 h after the tumor implantation, and 
were then given a suitable dose of sample for 10 consecutive days. It was found that 
only DB fraction could reduce the tumor weight significantly by 64% (Fig. 4.6). 
4.3.2 In vivo Antitumor Effect of Various Fractions of DB 
All the fractions derived from DB reduced the weight of solid tumor. At a dose 
of 20 mg/kg, DBc showed the highest reduction, and the tumor weight was reduced 
by 59%; whereas, DBb reduced the weight by 51 % (Fig. 4.7). 
When crude DI3 polysaccharides and DBc fraction were administered into 
tumor-bearing mice at different doses, both of them reduced the tumor weight 
dose-dependently. At 50 mg/kg, the effect of DBc was more prominent than that of 
DB. DBc reduced the tumor weight by 76% (Fig. 4.9), whereas DI3 reduced the 
tumor weight by 53% of the control level (Fig. 4.8). 
Neither crude DI3 polysaccharides nor DBc fraction could significantly affected 
the body weight of tumor-bearing mice when compared to the weight control group 
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Fig. 4.6 Effect of different DI fractions on tumor weight of Sarcoma 180 solid 
tumor-bearing mice. 
Three groups of mice received a dose of PBS, DI2 and DI3 fractions, 
respectively, for 10 consecutive days, 72 h after tumor implantation. 
The solid tumors were enucleated and weighed at 21 days after tumor 
inoculation. 
Results are expressed as mean (g) 士 S.D. (n=7) 
* represents statistical significance at p<0.05 when compared to the 
control level by Student Mest. 
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Fig. 4.7 Effect of different DI3 fractions on tumor weight of Sarcoma 180 solid 
tumor-bearing mice. 
Four groups of mice were administered with PBS, DBa, DBb and DBc 
fractions, respectively, for 10 consecutive days, 72 h after tumor 
implantation. 
The solid tumors were enucleated and weighed at 21 days after tumor 
inoculation. 
Results are expressed as mean (g) 土 S.D. (n=7) 
* and ** represent statistical significance at p<0.05 and pcO.Ol, 
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Fig. 4.8 Effect of different doses of crude DI3 polysaccharides on tumor weight 
of Sarcoma 180 solid tumor-bearing mice. 
Five groups of mice were administered with 0 (PBS alone), 12.5, 25, 50 
and 100 mg/kg of crude DI3 polysaccharides, respectively, for 10 
consecutive days, 72 h after tumor implantation. 
The solid tumors were enucleated and weighed at 21 days after tumor 
inoculation. 
Results are expressed as mean (g) 土 S.D. (n=8) 
*，** and *** represent statistical significance at p<0.05, pcO.Ol and 
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Fig. 4.9 Effect of different doses of DBc fraction on tumor weight of Sarcoma 
180 solid tumor-bearing mice. 
Four groups of mice was administered with 0 (PBS alone), 12.5, 25, 50 
mg/kg DBc fraction, respectively, for 10 consecutive days, 72 h after 
tumor implantation. 
The solid tumors were enucleated and weighed at 21 days after tumor 
inoculation. 
Results are expressed as mean (g) 士 S.D. (n=8) 
* and ** represent statistical significance at p<0.05 and pcO.Ol, 
respectively, when compared to the control level by Student Mest 
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Dose (mg/kg) Average body weight (g) 土 S.D. d 
Initial Final 
Weight control ^ 24.53 士 0.82 25.52 士 0.58 
Control b 23.15 ± 1.29 24.02 士 1.37 
DI3 ‘ 12.5 24.07 ± 1.23 24.57 ±1.56 
25 23.93 ± 1.09 24.69 ±1.30 
50 23.62 ±0.81 24.61 ±0.69 
100 23,20 ±0.82 24.25 ± 0.98 
Table. 4.5 Effect of different doses of crude DI3 polysaccharides on body weight 
of tumor-bearing mice. 
a The group of mice not implanted with tumor was served as the 
weight control. 
b & c The tumor bearing mice were given either PBS in control group or 
crude DI3 polysaccharides at different doses for 10 consecutive days, 
d The initial body weight was measured before the tumor inoculation. 
The final body weight was also determined after the enucleation of the 
tumor from the mice. 
Results are expressed as mean (g) 士 S.D. (n=8) 
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Dose (mg/kg) Average body weight (g) 士 S.D. ^ 
Initial Final 
Weight control ^ 23.61 ±0.79 25.10 ±0.97 
Control b 23.45 士 1.95 24.35 士 1.89 
DBc" 12.5 23.74 ± 1.28 24.66 ±1.14 
25 23.96 ± 1.05 24.92 ±1.25 
50 23.97 ±1.39 25.41 ± 1.37 
Table. 4.6 Effect of different doses of DBc fraction on body weight of 
tumor-bearing mice. 
a The group of mice not implanted with tumor was served as the weight 
control. 
b & e xhe tumor-bearing mice were given either PBS alone in control 
group or DBc fraction at different doses for 10 consecutive days, 
d The initial body weight was measured before the tumor inoculation. 
The final body weight was also determined after the enucleation of the 
tumor from the mice. 
Results are expressed as mean (g) 土 S.D. (n=8) 
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4.3.3 Effects of DBc on TNF-a and IL-2 Productions in Mice 
Levels of TNF-a and IL-2 in the blood of mice were measured by ELISA 
methods as stated in Section 3.3.4.3. Based on the previous experiment as shown in 
Fig. 4.8, administration of 12.5 mg/kg of DBc reached 68% tumor reduction. And in 
this study, administration of 12.5 mg/kg of DBc into the mice for 5 consecutive days 
in treatment groups exhibited that TNF-a levels in blood sera of DBc treated and 
DBc primed mice were significantly higher than that of the PBS control (Fig. 4.10, 
4.11 and Table 4.7). DBc fraction not only induced the production of TNF-a for 
about 4 folds, it also primed the LPS-triggered TNF-a production. On the other hand, 
the IL-2 levels in the blood sera of DBc-treated (Fig. 4.12) and DI3c-primed mice 
(Fig. 4.13) did not show any significant difference from that of the PBS control 
group. The standard curves for determining TNF-a and IL-2 levels are shown in Fig. 
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Fig.4.10 Effect of DI3c on serum level of TNF-a in mice. 
TNF-a concentrations were determined by ELISA using recombinant 
TNF-a as a standard 
Control group was given PBS only for 5 consecutive days. 
The DBc group was given DBc fraction at a dose of 12.5 mg/kg for 5 
consecutive days. 
The results were expressed as mean (pg/ml) 土 S.D. (n=4). 
** represents statistical significance at p < 0.01 when compared to the 
control level by Student 广-test. 
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Fig.4.11 Effects of DBc on serum level of TNF-a in LPS-primed mice. 
TNF-a concentrations were determined by ELISA using recombinant 
TNF-a as a standard 
PBS + LPS group consisted of LPS-primed mice, which had been given 
PBS only for 5 consecutive days. 
DBc + LPS group consisted of LPS-primed mice, which had been given 
DBc fraction at a dose of 12.5 mg/kg for 5 consecutive days. 
The results are expressed as mean (pg/ml) 土 S.D. (n=4). 
*** represents statistical significance at p < 0.001 when compared to the 
control level by Student Mest. 
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Fig.4.12 Effects of DBc on serum level of IL-2 in mice. 
IL-2 concentrations were determined by ELISA using recombinant IL-2 
as a standard 
Control group was given PBS only for 5 consecutive days. 
The DBc group was given DBc fraction at a dose of 12.5 mg/kg for 5 
consecutive days. 
The results are expressed as mean (pg/ml) 士 S.D. (n=4). 
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Fig.4.13 Effects of DBc on serum level of IL-2 in LPS-primed mice. 
IL-2 concentrations were determined by ELISA using recombinant IL-2 
as a standard 
PBS + LPS group consisted of LPS-primed mice, which had been given 
PBS only for 5 consecutive days. 
DBc + LPS group consisted of LPS-primed mice, which had been given 
DBc fraction at a dose of 12.5 mg/kg for 5 consecutive days. 
The results are expressed as mean 士 S.D. (n=4). 
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Serum cytokine (pg/ml) 
Treatments  
TNF-a IL-2 
PBS a 11.11 ±2.22 1.00 ±0.12 
DBcb 39.79 ±9.48 ** 1.22 ±0.06 
PBS + LPS ‘ 1093.72 ±307.18 1.54 ±0.59 
DBc + LPS d 2036.77 士 185.25 *** 1.43 士 0.36 
Table. 4.7 Effects of DBc on TNF-a and IL-2 production in mice. 
TNF-a and IL-2 concentrations were determined by ELISA using 
recombinant as a standard 
a PBS was administered i.p. to mice for 5 consecutive days 
DBc (12.5 mg/kg) was administered i.p. to mice for 5 consecutive 
days 
epBS was administered i.p. to mice for 5 consecutive days before LPS 
(10 |Lig) administration 
d DBc (12.5 mg/kg) was administered i.p. to mice for 5 consecutive 
days before LPS (10 |Lig) administration. 
The results are expressed as mean TNF-a or IL-2 concentration (pg/ml) 
± S.D. of four mice. 
Values that are significantly different from that of PBS control group 
were indicated by ** at p < 0.01 and *** at p< 0.005. 
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Fig. 4.14 Mouse TNP-a (Mono/Poly) standard curve. 
Serial dilution of 1000 pg/ml of recombinant mouse TNF-a was 
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Fig. 4.15 Mouse IL-2 (Mono/Poly) standard curve. 
Serial dilution of 200 pg/ml of recombinant mouse IL- 2 was used 
as the standard. 
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4.4 In vitro Effects of DI3 Fractions on Cell Density and Viability on Normal 
and Cancer Cell Lines 
4.4.1 Effects of DI3 Fractions on Proliferation and Viability of Human Leukemic 
HL-60 and K-562 cells and Mouse SarcomalSO Cells 
Trypan blue exclusion method was applied to study the in vitro effects of DI3 
fractions on proliferation and viability of the cancer cells. DI3 fractions did not 
significantly affect the density of K-562 (Fig. 4.16) and S-180 cells (Fig. 4.17), 
while DBb and DBc reduced dose-dependently the density of HL-60 cells (Fig. 
4.18). At the concentration of 200 jug/ml, DBb and DBc reduced the density of 
HL-60 cells by 50% and 39%, respectively. As shown in Table 4.8, the viability of 
HL-60, K-562 and S-180 were all over 98%. 
4.4.2 Effects of DI3 Fractions on the Growth of Human Liver Cancer HepG2 Cells 
and Normal Monkey Kidney Vero Cells 
MTT assay was applied to study the effects of DI3 fractions on the growth of 
HepG2 and Vero cells. DBb and DBc fractions reduced the growth of HepG2 cells 
in a dose-dependent manner (Fig. 4.19). At the highest concentration of 800 jug/ml, 
DBb and DBc reduced the growth of HepG2 cells by 39 % and 40 %, respectively. 
At 5-folds of the IC50 of DBb on HL-60 cells (i.e. 1000 |Lig/ml), all DBa, DBb and 
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DBc fractions did not show any significant effect on the growth of normal Vero 
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Fig. 4.16 Effect of different DI3 fractions on proliferation ofK-562 cells. 
Density of K-562 cells was determined by trypan blue exclusion after 
incubation with 100, 200, 400 and 800 |Lig/ml, respectivey, of different 
DI3 fractions for 72 h. 
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Fig. 4.17 Effect of different DB fractions on proliferation of S-180 cells. 
Density of S-180 cells was determined by trypan blue exclusion after 
incubation with 100，200, 400 and 800 |ig/ml, respectively, of different 
DB fractions for 72 h. 
Results are expressed as mean 士 S.D. (n=3) 
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Fig. 4.18 Effect of different DI3 fractions on proliferation of HL-60 cells. 
Cell density of HL-60 cells was determined by trypan blue exclusion 
after incubations with 100, 200, 400 and 800 |Lig/ml, respectively, of 
different DI3 fractions for 72 h. 
Results are expressed as mean 土 S.D. (n=3). 
*，** and ** represent statistical significance at p< 0.05, p< 0.01 and p< 




Samples Concentration Viability (%) 
(|Lig/ml) HL-60 K-562 S-180 
Control 0 99.5 ± 1.0 99.8 ± 0.3 99.6 ± 0.0 
DI3a 100 98.9 ±0.1 99.5 ±0.5 98.9 ±0.3 
200 99.5 ±0.0 99.6 ±0.3 99.3 ± 0.5 
400 99.2 ±0.4 99.6 ±0.7 99.5 ± 0.5 
800 99.0 士 0.7 99.8 士 0.3 99.9 士 0.2 
DI3b 100 98.7 土 0.9 99.1 ±0.8 99.6 ± 0.5 
200 98.4 土 0.6 99.6 士 0.3 99.4 士 0.3 
400 97.9 土 0.7 99.8 土 0.3 99.7 士 0.6 
800 98.0 ±0.8 99.3 ±0.3 99.8 ± 0.3 
DBc 100 99.0 ±0.7 99.7 ± 0.3 99.7 土 0.3 
200 99.0 士 0.3 99.8 土 0.3 99.9 士 0.2 
400 98.8 ±1.1 99.6 ±0.6 99.6 士 0.4 
800 98.9 士 1.1 99.6 ±0.7 99.9 ± 0.3 
Table.4.8 Effects of different DI3 fractions on viability of HL-60, K-562 and 
S-180 cells after 72 h of incubation. 
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Fig. 4.19 Effects of different DI3 fractions on the growth of HepG2 cells. 
The growth of HepG2 cells was measured by MTT assay after incubation 
with 100, 200, 400 and 800 |Lig/ml, respectively, of different DI3 fractions 
for 72 h. 
Results are expressed as mean 士 S.D. (n=3) 
* represents statistical significance levels at p< 0.05 when compared to 
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Fig. 4.20 Effects of different DI3 fractions on the growth ofVero cells. 
The growth of Vero cells was determined by MTT assay after incubation 
with 100, 200, 400 and 800 |Lig/ml, respectively, of different DI3 fractions 
for 72 h. 
Results are expressed as mean 土 S.D. (n=3). 
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4.4.3 Effect of DBb Fraction on Proliferation of HL-60 Cells Determined by BrdU 
Incorporation 
To further verify the effect of DBb fractions on the growth of cancer cells, 
BrdU incorporation was used to study the effect of the polysaccharides on 
proliferation of human leukemic HL-60 cells. As BrdU is an analogue of thymidine 
and its incorporation level into cellular DNA, it was used in order to detect and 
visualize cell proliferation at the individual cell level. After co-incubation with DBb 
for 72 h, the BrdU incorporation into the cellular DNA of HL-60 cells was 
significantly reduced in a dose-dependent manner (Fig. 4.21). DBb reduced the 
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Fig. 4.21 Effects of different concentrations of DBb fraction on BrdU 
incorporation in HL-60 cells. 
The proliferation of HL-60 cells was indicated by the level of BrdU 
incorporations after incubation with 100, 200, 400 and 800 |Lig/ml, 
respectively, of DBb fractions for 72 h. 
Results are expressed as mean 士 S.D. (n=3). 
* and *** represent statistical significance at p< 0.05 and p< 0.001, 





5.1 Extraction and Characterization of DI3 Fractions 
In this study, dried fruit bodies of Dicytophora indusiata were subjected to hot 
water extraction to isolate the water-soluble components. In order to carry out 
thorough extraction, the process was repeated three times and each time lasted for 
2-3 hours. The percentage yield of the water extracts from the dried fruit bodies was 
29.67%. Since water-soluble polysaccharide-enriched fraction was commonly 
isolated by hot water extraction followed by precipitation with ethanol, fractional 
precipitations by stepwise additions of ethanol up to different concentrations were 
employed after the water extract was concentrated in this study (Liu et al., 1996b; 
Wang et al., 1997). The water-soluble polysaccharides were then separated into 
relatively higher and lower molecular weight polysaccharides by 40% and 80% 
ethanol precipitations, respectively. These two obtained crude polysaccharides were 
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designated as DI2 and DI3. 
In the preliminary in vivo antitumor study of crude polysaccharides DI on 
Sarcoma 180 solid tumor, DIl did not show any inhibitory effect; therefore it was 
eliminated in this study. As comparing the effect of DI2 and DI3 polysaccharides, 
DI3 at the dose of 100 mg/kg inhibited the growth of solid tumor significantly by 
64%, which was more prominent than DI2 polysaccharides. Therefore, DB crude 
polysaccharides were chosen to undergo further bioactivity guided fractionation. 
After ethanol precipitations, further separation of DI3 fraction was achieved by 
anion exchange chromatography. Acid polysaccharides were isolated from the 
neutral materials, and the separation of acid polysaccharides with different ionic 
strength and acidity grades was also achieved. In this study, DEAE-cellulose was 
used as the matrix of the chromatography. Under neutral conditions, DEAE-cellulose 
scarcely absorbs neutral polysaccharides, which can be eluted readily by distilled 
water (Scherz & Bonn, 1998). The retained polysaccharides can be eluted 
quantitatively with appropriate concentration of sodium chloride solution. The DI3 
fraction isolated by ethanol precipitation was dissolved in distilled water, washed 
into the DEAE-cellulose column, and fractionated with a 0 to 1 .0 M sodium chloride 
solution gradient. The presence of polysaccharides was detected by phenol sulfuric 
assay (Dubosi et al, 1956). According to the result, in addition to the peak that was 
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eluted by distilled water, there were two more peaks appeared and were eluted by 
0.04 M and 0.5 M NaCl, respectively. DI3a fraction, which was eluted by distilled 
water, was composed of neutral polysaccharides, whereas both DI3b and DBc 
fractions consisted of acid polysaccharides. Among the three fractions, DI3a 
constituted the highest proportion (69.4%) and DI3b constituted the lowest (9.2%) in 
the crude DI3 polysaccharides. Recovery of the three fractions from the crude DI3 
polysaccharides after fractionation was satisfactory (up to about 90%). 
In order to determine the polysaccharides within DI3 fraction, phenol sulfuric 
assay was used in this study. Phenol sulfuric assay is a reliable method that can be 
used to measure the sugar content in aqueous solution. Under proper conditions, such 
as the amount of phenol added and incubation time, the accuracy of this method can 
be up to 98% (Dubois et al., 1956). Besides, this method is simple and the color 
produced is stable, which gives a definite absorption peak and can be quantified 
easily by a spectrophotometer. 
Lowry-Folin method, instead of the Bicinchoninic acid assay (BCA), was used 
in this study to determine the protein content in the DI3 fractions. The Lowry-Folin 
method is based on both the Biuret reaction in which Cu^^ is reduced to Cu^ ,^ and the 
Folin-Ciocalteau reaction in which Cui+ reacts with Folin-Ciocalteau reagent to form 
the final intense color. Lowry-Folin method was chosen since it is less sensitive to 
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the presence of reducing sugars than the BCA assay (Smith et al., 1985). 
The results showed that polysaccharides was the major component in DI3 
fraction (>70%), but it was not the only component that was present in the three DI3 
fractions. The DIB fraction contained 12% of protein and 64%of polysaccharides in 
the sample. Among the three DI3 fractions, DI3a and DBc contained the highest 
amounts of polysaccharides (94%) and proteins (25%), respectively. 
Since higher concentrations of sodium chloride solution elute polysaccharides 
fractions with higher ionic strength and acidity from the DEAE-cellulose column, it 
is not surprised that DBc fraction contains the highest amount of uronic acid. 
Besides, as detected by gas chromatography, the monosaccharide profiles of 
DI3 fraction contained galactose, glucose, mannose and with trace amount of xylose. 
However, the ratio of monosaccharides present in DBc is different from those 
present in DI3a and DI3b, respectively. The major constituent in DBc fraction is 
glucose but the major constituent in both DI3a and DI3b fractions is mannose. 
As shown by HPLC study, DBc fraction was a relatively homogenous 
polysaccharide. The average molecular weight of DBc polysaccharide, which was 
determined by measuring the retention times of the peak and compared it to the 
dextran standard, is 3.3 kDa. DI3b and DBc fractions, on the other hand, contained 
two and three groups of polysaccharides, respectively. 
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With references to the findings of the previous studies, many of the antitumor 
mushroom polysaccharides are protein-containing polysaccharides, which are similar 
as that in DBc fraction. The protein contents within the polysaccharides from 
mushroom Tricholoma mongolicum, Pleutrotus sajor-caju and Coriolus versicolor 
range from about 11% to 24%, whereas that in the fraction of DI3 ranges 3-25% 
(Zhuang et al., 1993; Tsukagoshi et al” 1994; Wang et al., 1996a). 
Moreover, the main constituent of other reported polysaccharide T-2-HN and 
T-3-M from Dictyophora indusiata, which are 0-acetylated (l->3)-a-D-mannan and 
a-(l->3)-linked D-mannan, is mannose. It was found DI3a and DBb 
polysaccharides fractions, like T-2HN and T-3-M, are also mainly composed of 
mannose (Hara et al., 1982a; Hara et al., 1988). 
Besides, as compared the molecular weight of the DI3 fractions with the 
polysaccharides extracted from Dictyophora indusiata by Hara et al. and Ukai et al. 
(stated in Table 2.1), the average molecular weight of DBc fraction is much smaller 
3.3 kDa) than those extracted by Hara et al. and Ukai et al. (>10 kDa). 
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5.2 Antitumor Effects of Dictyophora indusiata Polysaccharides 
In order to investigate the in vivo antitumor effects of Dictyophora indusiata 
polysaccharides, 7-8 weeks old male BALB/c mice were used in this study. BALB/c 
mice were commonly used in many other studies, and the use of male mice is to get 
rid of the influence of hormonal changes in female mice. Besides, the mice used 
were acclimatized for a week before starting of each experiment, so as to minimize 
the variation of mice within the group. After inoculation of S-180 cells into the back 
of the mice, they were left for 3 days before i.p injection of the sample. The reason 
for that is not only to allow time for the development of solid tumor, but also to 
mimic the situation that treatments always received after the occurrence of tumor. 
According to the results, DI3 was more effective than DI2 in inhibiting the 
growth of Sarcoma-180 tumor, which gave an inhibitory rate of 64%. DI3 was 
further fractionated into three fractions: DBa，DBb and DBc. 
Among the three polysaccharides fractions of DI3, DBc was the most potent 
fraction in inhibiting the growth of S-180 tumor, however, the antitumor effect of 
DBa fraction was not significant. It was not surprised that the neutral 
polysaccharides fraction of DI3 exhibited lesser antitumor activity, since the neutral 
polysaccharides from Tricholoma sp. (strain STC20-T1) also exhibited the least 




In order to compare the antitumor effects of DI3 polysaccharides before and 
after fractionation in DEAE-cellulose column, DB crude polysaccharides and DBc 
fraction at different doses were administered to the tumor-bearing mice. Both the two 
fractions possess antitumor activity dose-dependently. This is in agreement with the 
previous reports, that CF-1 and CF-4 of Griofola frondosa polysaccharides and GL-B 
of Ganoderma lucidum polysaccharides also inhibited the growth of tumors 
dose-dependently (Ohno et al., 1984; Zhang & Lin, 1999). Furthermore, the minimal 
doses of the crude DB polysaccharides and fractionated DI3 fractions that 
significantly inhibit the tumor growth were found to be 25 mg/kg and 12.5 mg/kg, 
respectively. DBc fraction was found to posses the most effective antitumor activity 
in the present study. However, the anticancer activity was relatively less effective 
when compared to some of the mushroom polysaccharides administered at similar 
doses or even at lower dose. Schizophyllan has been found to induce complete 
regression of Sarcoma 180 solid tumor in Swiss mice treated with a dose of 10 mg/kg 
for 10 consecutive days (Komatsu et al., 1969). Lentinan also induced complete 
regression of S-180 tumor in ICR mice treated with a dose of 1 mg/kg for 10 
consecutive days (Chihara et al., 1970). The difference in effectiveness may be due 
to the uses of different strains of mice. Further studies are required to demonstrate 
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the antitumor effect of DBc in other strains of mice. 
Although the extraction method used in this study was not targeted on the 
isolation of glucan from mushroom Dictyophora indusiata, which was not the same 
as that in the isolation of PSK (Krestin) from mushroom Coriolus versicolor, the 
result showed that the proteins amount and monosaccharides profile of DBc fraction 
was very similar to that of PSK. PSK (Krestin), which is used clinically in anticancer 
treatment, is a p-D-glucan complex containing 25-38% protein. It was mainly made 
up by glucose with small amount of maimose, fucose, xylose and galactose 
(Tsukagoshi et al., 1984). In DI3c fraction, 25% of its weight was protein residue, 
and the major constituent monosaccharide is glucose with small amount of mannose, 
galactose and xylose, Therefore, DBc fractions may be an antitumor glucan linked 
with heterosaccharide chains of galactose and mannose and it may not be neglected 
the possibility that the protein part of DBc fraction may also participate in the 
antitumor activity on tumor-bearing mice. Further studies are demanded to compare 
the antitumor activities of the polysaccharopeptides, polysaccharides and proteins 
components of the DBc fraction. 
Since there were no significant changes in body weight of the DI3c-treated 
group as compared to that of the normal weight control, it manifested that 
administration of DBc did not affect the increase in body weight. Besides, no death 
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of mice was observed either in control or treatment group throughout the 
experiments. Accordingly, DBc fraction may not be thought to display antitumor 
activity through direct toxicity action against tumor cells. 
Cytokines system is a key-contributing factor in the immune system and 
inflammatory responses (Kelso, 1998). Many of the mushroom polysaccharides that 
show antitumor responses have been found to associate with immunomodulating 
cytokine production in vivo, such as the two well-known medicinal mushroom 
polysaccharides, schizophyllan and PSK (Ooi & Liu, 1999). 
To gain insight into the antitumor activity by DBc fraction, sandwich type 
enzyme-linked immunosorbent assay (ELISA) was used to study the modulatory 
activities of DBc fraction on cytokine production. This assay method is highly 
sensitive and can detect the presence of cytokines, but also can determine the 
cytokine production at very minute quantity (pg/ml) (Caponi and Migliorini, 1999). 
Previous studies have shown that mushroom polysaccharides and proteins modulate 
TNF- a and IL-2 productions in vivo. PSK and GLP increased the expression level of 
TNF-a in peritoneal exudates cells of mice (Liu et al., 1996b; Hsu et al., 1997). And 
Fip-wo, a protein purified from mushroom Volvariella volvacea, was shown to 
elevate the expression level of IL-2 in splenocytes of mice (Ooi et al., 2002). In this 
study, the immunomodulatory effect of DBc fraction on TNF-a and IL-2 production 
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in BALB/c mice was investigated. Administration of 12.5 mg/kg DBc fractions for 5 
consecutive days produced an elevated level of TNF-a. LPS administration in normal 
mice further elevated the TNF-a production. However, the concentration of IL-2 in 
blood sera of mice did not shown any significant changes. Bacterial 
lipopolysaccharides (LPS), which responsible for immune response, can activate 
macrophages to release cytokines including TNF-a, IL-1 and IL-6 (Nathan, 1987). 
Therefore, the priming effect of TNP-a production by DBc fraction is strongly 
related to the activation of macrophages. Since TNF-a possess direct cytotoxicity on 
tumor cells via apoptosis and necrosis, and the TNF-a production would further 
activate the macrophage to produce more TNF-a (Brophy, 2001), the inducing effect 
of TNF-a demonstrated the antitumor action of DBc fraction when it was 
administered in tumor-bearing or normal mice. As reported by Ohno et al (1995), a 
(1—3)_P_ghican from Grifola frondosa (GRN) also showed the priming effect of 
TNF-a production in ICR, MRL/1 pr as well as BALB/c mice (Ohno et al., 1995). 
Apart from in vivo antitumor study, four different cancer cell lines, including 
human leukemic HL-60 and K-562 cells, human liver cancer HepG2 cells and mouse 
Sarcoma 180 cells, were used to investigate the antiproliferation and cytotoxic effects 
in vitro. In order to study the growth of different cancer and normal cell lines after 
incubation with different DI3 fractions, either trypan blue exclusion method or MTT 
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reduction assay were used. The growth of HL-60, K-562, S-180 and HepG2 cancer 
cells were not inhibited by DI3a fraction. Since DI3a fraction contains mainly of 
neutral polysaccharides, it implies that neutral polysaccharides may not have 
antitumor activities. 
DI3b and DBc fractions were able to inhibit the proliferation of HL-60 and 
HepG2 cells dose-dependently. Although the efficacies of DI3b and DBc on 
reducing the growth ofHepG2 cells are about the same, DI3b was a more effective in 
inhibiting the proliferation on HL-60 cells when compared to DBc. DI3b at 800 
jig/ml inhibited the growth of HL-60 cells by 68%, while only 57% of inhibition was 
observed with DBc fraction. It is rare that mushroom polysaccharides inhibit the 
proliferation of cancer cell directly. Polysaccharides from Ganoderma lucidum 
MGLPl did not show inhibition of HL-60 proliferation up to 750 |Lig/ml. However 
apoptosis was observed after the cells have been incubated with the conditioned 
medium from MGLPl activated splenocytes (MGLP-S-CM) (Hu and Lin, 1999). 
Therefore, it was interesting that both DI3b and DBc could inhibit the proliferation 
of HL-60 in vitro. 
In a further study, BrdU incorporation in HL-60 cells was measured after 
incubation with different concentrations o fDBb fraction to verify the effect of DI3b 
fraction on proliferation of HL-60 cells. The BrdU incorporation was decreased by 
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54% of the control level after incubation with DBb fraction at 800 |xg/ml for 72 h. 
Since BrdU is an analogue of thymidine and its incorporation level into the cellular 
DNA is a measure of proliferation, the decrease in BrdU incorporation indicated 
inhibition of HL-60 cell proliferation by DBb fraction. In the previous studies, this 
method has also been utilized by Huong et al. (1991) and Magaud et al. (1988), 
respectively, to measure the proliferation of human lymphocyte. Both trypan blue 
exclusion and BrdU incoporation assays showed that DBb fraction inhibited the 
proliferation of HL-60 cells dose-dependently. 
DI3 fractions did not retard the growth ofVero cells even when the dose was up 
to 5-folds of the I C 5 0 of DBb fractions on HL-60 cells. The viability of HL-60, 
K-562 and S-180 were all over 98%. All these results imply that the antiproliferative 
action of DI3 fractions on HL-60 cells may be modulated by cell cycle regulation 
(Kawamura et al., 2000), rather than by inducing apoptosis or necrosis (direct 
cytotoxicity). 
According to the previous in vivo study, the DBc fraction showed inhibition of 
S-180 cells at a minimal dose of 12.5mg/kg. However, DI3 fractions did not show 
any antiproliferative effect toward S-180 tumor cell line in vitro. Moreover, DI3 
fractions did not show direct cytotoxic effects on Vero cells. All these results support 
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5.3 Further Studies 
In this study, it was found that DBc is the most prominent fraction in inhibiting 
the growth of S-180 in tumor-bearing mice, and the possible mechanism of antitumor 
activity may be due to the elevated TNF-a level in blood serum. However, this study 
only targets on two of the cytokines, namely TNF-a and IL-2. As in the study by Liu 
et al (1999), up-regulation of gene expression of IL-la, IL-1(3, TNF-a, IFN-y and 
M-CSF by PSPC and lentinan, respectively, were detected in mice, other cytokines 
such as interferons or different types of interleukin, can also been chosen for further 
study (Liu et al； 1999). Since DBc is a relatively homogenous fraction and is 
composed of small molecular weight polysaccharides (3.3 kDa) with high water 
solubility, it is worth to develop this fraction as an antitumor injectant. Furthermore, 
since different dosage and timing of administration may also alter the efficiency 
(Wang and Zheng, 1997), more studies are required to investigate the optimal 
administration schedule of DBc. 
Apart from the in vivo antitumor effect of DBc, DBb is also a potent fraction in 
inhibiting the proliferation of HL-60 and HepG2 cancer cells. Although the 
antiproliferative effect of DBb is prominent on these two cancer cells, especially on 
HL-60 cells, the impurity in DBb may affect the antitumor efficacy of this fraction. 
Therefore, further fractionation and purification of this DBb fraction in Sepharose or 
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Sephadex column is required to obtain relatively more purified compounds for 
further investigation. 
Since, the antiproliferative activity of DI3b fraction may be due to the cell cycle 
regulation, the mechanism of DI3b in inhibiting the proliferation of cancer cells can 
be studied in more detail. With the aid of flow cytometry or by using western blot 
analysis, the status or the level of the cell cycle regulatory proteins, for examples the 






In the present study, three mushroom polysaccharide fractions have been 
isolated from the fruit bodies of edible mushroom, Dictyophora indusiata, which are 
designated as DBa, DBb and DBc, respectively. 
All of the three fractions have been subjected to in vivo and in vitro antitumor 
studies. DBc fraction, which comprises of polysaccharopeptide of 3.3 kDa and 
contains 25% of proteins, is the most prominent fraction in inhibiting the growth of 
S-180 in tumor-bearing mice. The antitumor effect of DBc fraction is 
dose-dependent and at dosage of 50 mg/kg, the inhibition rate was up to 76%. DBb 
fraction, which consists of three groups of polysaccharides, is the most prominent 
fraction in inhibiting the proliferation of cancer cells in vitro. DBb inhibits the 
proliferation of HL-60 and HepG2 cells dose-dependently and the I C 5 0 of DBb 
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fraction on HL-60 cells was 200 |Lig/ml. 
DBc elevates serum TNF-a level showing that the in vivo antitumor effect of 
DBc may be mediated by TNF-a induction, which is cytotoxic on the cancer cells 
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